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ABSTRACT
Diabetes, the seventh leading cause of death in the United States (Centers for Disease Control
and Prevention [CDC], 2020a) and the ninth leading cause of death worldwide (World Health
Organization [WHO], 2020), has increased by 70% over the last two decades (WHO, 2020).
Type 2 diabetes (T2D), the most prevalent type accounting for 90% to 95% of diagnosed cases
(CDC, 2020a), affects individuals of all ages and often results in major health problems
including stroke, heart attack, and kidney disease. The purpose of this patient-centered,
evidence-based practice (EBP) project was to evaluate the effectiveness of a multimodal
intervention on hemoglobin A1c (HgbA1c) levels and diabetes self-management (DSM)
behaviors. Adults who were 18 years of age or older, had T2D, and desired to make lifestyle
changes (n = 33) were recruited at a rural primary care office in Northern Indiana to participate
in the project. Participants set individualized, specific, measurable, attainable, realistic, and
time-specific (SMART) goals, received a packet containing DSM educational supplements and
tools, and received frequent follow-up at 2, 4, and 8 weeks by way of reminder letters and a
progress telephone call. Prior to and 12 weeks after enrollment, a HgbA1c level was evaluated,
and a self-report DSM questionnaire (DSMQ) was administered. Data were analyzed using
paired t-tests to compare pre- and post-intervention HgbA1c levels and DSMQ scores and
determine the effectiveness of the multimodal intervention. The primary outcome demonstrated
a reduction in mean HgbA1c levels from pre- to post-intervention. Secondary outcomes
demonstrated improvements in DSM behaviors related to diet, physical activity, and blood
glucose monitoring following implementation of the intervention. Additional secondary outcomes
demonstrated individual satisfaction with the intervention, and participants reported helpfulness,
benefit, and improved accountability as a result of the intervention. Findings from this EBP
project support the use of a multimodal intervention in the treatment plan for diabetic patients
and will be discussed.
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CHAPTER 1
INTRODUCTION
Background
Diabetes mellitus, a common non-infectious disease typically referred to as diabetes,
remains the seventh leading cause of death in the United States (U.S.) (Centers for Disease
Control and Prevention [CDC], 2020a) and the ninth leading cause of death worldwide (World
Health Organization [WHO], 2020). Over the last two decades, the number of global cases of
diabetes has significantly increased, at an alarming rate, by 70% (WHO, 2020). In 2019, an
estimated 87,647 American deaths (CDC, 2020b) and 1.5 million global deaths (WHO, 2021a)
were directly related to diabetes. Diabetes is defined as a metabolic disease characterized by a
consistently elevated blood sugar caused by a lack of insulin secretion or action (American
Diabetes Association [ADA], 2019). This condition affects individuals across the lifespan:
children, adults, and the elderly. Diabetes can lead to major health problems including stroke,
heart attack, kidney disease, blindness, and amputation of the lower extremities (ADA, 2019;
WHO, 2021a). In 2017, direct medical care and decreased workforce productivity in the U.S.,
attributed to diabetes, cost $327 billion (ADA, 2021). Although there are four types of diabetes
(a) type 1, (b) type 2, (c) gestational, and (d) diabetes due to other causes, for the purpose of this
evidence-based practice (EBP) project and manuscript, only type 2 diabetes (T2D) will be
discussed.
Type 2 is the most prevalent type of diabetes, accounting for 90% to 95% of diagnosed
cases (CDC, 2020a). This condition results from insulin resistance or deficiency due to an
impairment in insulin production (ADA, 2019). Insulin acts as an essential hormone which allows
glucose to be transported from the bloodstream to certain body tissues and used as energy
(Gilman, 2020). The exact cause of T2D is unknown; however, obesity or an increased
percentage of body fat has been contributed to causing insulin resistance, and genetics may also
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play a role in the development (ADA, 2019). Type 2 diabetes often remains undiagnosed for
multiple years because high blood sugar levels typically develop slowly overtime. Risks of
developing T2D include but are not limited to advancing age, obesity, and physical inactivity. The
confirmation of T2D is made by blood testing, and certain criteria set forth by the ADA must be
met. The criteria for diagnosis include either of the following: (a) symptoms of high blood sugar
coinciding with a random plasma glucose level that is equal to or greater than 200 mg/dL or (b)
two abnormal results: e.g., a fasting plasma glucose that is equal to or greater than 126 mg/dL, a
plasma glucose that is equal to or greater than 200 mg/dL, and/or a serum hemoglobin A1c
(HgbA1c) that is equal to or greater than 6.5% (ADA, 2019).
To help decrease morbidity and mortality, a healthy diet, regular physical activity, and
healthy weight maintenance are recommended by the ADA (Riddle et al., 2019) and the
American Association of Clinical Endocrinology (AACE) (Garber et al., 2020) as essential
primary and secondary prevention interventions for those who are either at risk of developing or
have previously been diagnosed with diabetes. Although a healthy lifestyle centered around diet,
physical activity, and weight maintenance is a strong EBP recommendation, utilization of these
interventions has been lacking by patients in the primary care setting since documented by
Nelson et al. in a classic research study published in 2002. Of 1,480 U.S. adults who were
diagnosed with T2D, over 60% of participants lacked the recommended daily nutritional intake
and level of physical activity (Nelson et al., 2002). Furthermore, 82% of the participants had a
body mass index (BMI) classified as either overweight or obese (Nelson et al., 2002).
Unfortunately, since Nelson and colleagues published their study in 2002, the prevalence rates
of diabetes and obesity within the U.S. have worsened (State of Childhood Obesity [SCOB],
2020). The WHO (2021b) reported a 5% increase of insufficient physical activity in countries with
a higher income such as the U.S. since 2001.
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Data Supporting Need for the Project
Global, National, Regional, and State Data
As noted previously, diabetes is very prevalent worldwide, and global and national
statistics are likely to actually be higher due to an under-reporting of cases (CDC, 2020a). In the
U.S. alone, diabetes affects more than 34 million Americans, approximately 13% of adults (CDC,
2020c) and 10.5% of the total U.S. population (ADA, 2021). Interestingly, it is estimated that 20%
of these 34 million Americans remain undiagnosed and are unaware of having diabetes (ADA,
2021; CDC, 2020a), yet the ADA (2021) and National Diabetes Statistics Report detail a national
incidence rate of 1.5 million newly diagnosed cases of diabetes each year in the U.S. (CDC,
2020c). The increasing number of individuals living with diabetes is a concern as diabetes
attributed to 87,647 American deaths (CDC, 2020b) and 1.5 million global deaths (WHO, 2021a)
in 2019.
Within the U.S., the prevalence of diabetes among adults who live in the Midwest region
ranges from 8% to 15.9% (SCOB, 2020). Unfortunately, Indiana was ranked as one of the top 10
states within the U.S. to have the highest number of diagnosed diabetes cases in 2019 (SCOB,
2020). Even more disturbing, Indiana has the highest prevalence of diabetes within the Midwest
at a rate of approximately 12.4% (Indiana State Department of Health [ISDH], 2019; SCOB,
2020). In 2018, it was estimated that 639,444 Indiana adults (12.48%) had a confirmed diagnosis
of diabetes (ISDH, 2019); Thus, the prevalence rate for Indiana is higher than the U.S. national
average of 10.5%. The number of cases in Marshall and St. Joseph counties, the surrounding
areas in which this EBP project was implemented, are 3,968 and 18,157 respectively (ISDH,
2019), with prevalence rates for these counties at 8.58% and 6.68%, respectively (ISDH, 2019).
Clinical Agency Data
Although the prevalence rates for the local counties were below the national and state
averages, the healthcare providers at a family practice primary care office located in Northern
Indiana communicated a desire for an intervention aimed at improving patients’ diabetes self-
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management (DSM) behaviors and glycemic control. This primary care office consisted of two
family practice providers, one physician and one nurse practitioner who also served as the
practice’s diabetic educator. The project leader completed a semester of clinicals at this primary
care office working alongside the physician during the spring of 2021. During that time, the
project leader was able to experience first-hand how prevalent the diagnosis of diabetes was
within the practice’s patient population. Additionally, the physician and project leader briefly
reviewed the prevalence of elevated HgbA1cs in their patient population within the past year.
This further supported the need for an intervention focused on DSM. During the summer of 2021,
the project leader completed an in-depth review of patient charts in which a diagnosis of diabetes
or an elevated HgbA1c had been previously confirmed. Of about 2,300 patients seen by these
providers, approximately 250 patients had diabetes. With a prevalence rate near 10.8%, this
primary care office exceeded not only the rate of diabetes of both Marshall and St. Joseph
counties but also the national rate. Also, during the in-depth chart review, the project leader
noted that many patients had reported a desire to attempt lifestyle changes prior to any
pharmacotherapy interventions. Such patient input was a driving force within project
development as it highlighted the need for interventions consistent with this preference.
Purpose of the Evidence-Based Practice Project
Purpose Statement and PICOT Question
The purpose of this patient-centered, EBP project was to evaluate the effectiveness of a
multimodal intervention involving goal setting, educational supplements and tools centered
around DSM, and frequent follow-up on HgbA1c levels and DSM behaviors. Specifically, this
project addressed the following PICOT question: In adults who have T2D (P), how does the
implementation of a multimodal intervention to encourage self-management (I) compared to
current practices (C) impact HgbA1c levels (O) over a 12-week period (T)?
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EBP Project Description
This patient-centered EBP project, entitled Back to the Basics with Smart Goals: A
Multimodal Intervention for Adults Who have Type 2 Diabetes, involved three essential
interventions intended to empower patients who have T2D to better self-manage their diagnosis.
These interventions included individualized goal setting by the patient under the guidance of their
family practice provider or the project leader, a packet containing DSM educational supplements
and tools to be used as appropriate by the patient, and frequent follow-up by the project leader in
the form of two letters to serve as reminders of set goals at 2 and 8 weeks and one progress
telephone call at 4 weeks. Participants were recruited by either their family practice provider or
the project leader at their already scheduled annual wellness visit or diabetes follow-up
appointment. Adults, those over the age of 18, who had been previously diagnosed with T2D and
expressed a desire to make lifestyle changes were invited to participate in the project.
Additionally, those whom the family practice providers thought may benefit from the intervention
and met the inclusion and exclusion criteria, which will be discussed further in Chapter 3, were
also invited to participate in the project. The primary and secondary outcomes measured were
glycemic control and DSM behaviors, respectively. Glycemic control was measured by point-ofcare (POC) HgbA1c levels while DSM behaviors were measured by the Diabetes SelfManagement Questionnaire (DSMQ). Both HgbA1c levels and the DSMQ scores were assessed
at each patient’s visit prior to the start of the intervention and again at the routine 12-week
diabetes follow-up appointment. Patient satisfaction of the multimodal intervention was also
evaluated at these follow-up appointments.
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CHAPTER 2
EBP MODEL AND REVIEW OF LITERATURE
Evidence-Based Practice Model
Overview of EBP Model
The EBP model chosen to serve as a guide for this project was the Iowa Model Revised.
The Iowa Model Revised, formerly known as the Iowa Model, acts as a decision-making guide
for nurses and healthcare providers in both the clinical and administrative settings (Buckwalter et
al., 2017; Dang et al., 2019). The goal of this model is to improve outcomes and promote
excellency in healthcare through the implementation of evidence-based practices. The Iowa
Model Revised consists of seven steps: (1) identifying triggering issues or opportunities, (2)
stating the question or purpose, (3) forming a team, (4) assembling and synthesizing the body of
evidence, (5) designing and piloting the practice change, (6) integrating and sustaining the
practice change, and (7) disseminating the results. Three decision points, located at the end of
steps 2, 4, and 5, aid the user in determining topic priority, sufficiency of evidence, and
appropriateness of EBP change. These decision points are pertinent to the model as they
provide feedback loops throughout allowing the user to revisit previous steps as necessary.
The Iowa Model Revised was chosen by the project leader for multiple reasons. This
model is widely recognized by nursing organizations including Sigma Theta Tau International,
interdisciplinary healthcare teams and professionals, and many countries worldwide (Buckwalter
et al., 2017; Dang et al., 2019). The steps, decision points, and feedback loops within the model
support its ease of use and applicability in the clinical setting. The Iowa Model Revised has also
allowed users to establish clear boundaries, set an appropriate target, and utilize a more focused
approach to help achieve successful EBP change. Additionally, this EBP model was chosen
because it supported the engagement of patients as key stakeholders, the incorporation of
patient preferences and values, and the consideration of the patient-partnership as an ongoing
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priority. The use of the Iowa Model Revised was appropriate for this EBP project because of its
emphasis on patient-centeredness and the structure of its framework.
Literature Search
Sources Examined for Relevant Evidence
Under the guidance of Valparaiso University’s College of Nursing & Health Professions
Research Services Librarian, exhaustive, systematic searches for relevant, scholarly, and highquality articles were conducted using the Joanna Briggs Institute (JBI), Cochrane Library,
Turning Research into Practice (TRIP), Cumulative Index of Nursing and Allied Health Literature
(CINAHL), and MEDLINE with Full Text databases. The reference lists of the yielded articles
from the searches were also reviewed, and applicable articles were retrieved through Valparaiso
University’s Summons search engine by means of citation chasing. Keywords of the clinical
question (diabetes, self-management, and hemoglobin A1c) were used as the foundation for the
searches and Boolean operators (AND/OR) were utilized. The final search terms used across the
databases included the following: “diabetes mellitus”, “type 2”, self-manag*, manag*, self-care,
and “hemoglobin a1c”. To refine the search further in CINAHL and MEDLINE, an exact major
subject heading, (MM “Diabetes Mellitus, Type 2”), was incorporated. The search strategy for
each database is clearly listed on the literature search grid in Appendix A and will be briefly
discussed below following discussion of the inclusion and exclusion criteria.
Inclusion criteria were applied to the searches to ensure relevant, scholarly, and highquality pieces of evidence were chosen to support this EBP project. Inclusion criteria, or limits,
consisted of peer reviewed articles that were written within the past 5 years from 2016 to 2021
and available in the English language. Additional inclusion criteria in the TRIP database included
guidelines. These limits combined with the above-mentioned final search terms resulted in a total
of 429 sources from the five databases. Thirteen additional sources were identified by means of
citation chasing.
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From the resulting sources, exclusion criteria were applied by the project leader to ensure
appropriate sources were chosen to support the EBP project and needs of the project site.
Systematic protocols were excluded because they are in the review stage and not considered
high pieces of evidence. Duplicate sources within and between databases were manually
excluded by the project leader. Additional exclusion criteria included sources that were focused
on the pediatric population, pregnant or lactating women, acute care, other comorbidities or
diagnoses like type 1 diabetes, heart failure, kidney disease, cancer, etc., pharmacotherapy, and
technology. Sources that were limited to countries other than the U.S. or culturally tailored,
lacked an outcome measure, or were not classified as level one pieces of evidence were also
excluded. After a careful and thorough review of all eligible sources, 14 pieces of evidence were
chosen by the project leader to help aid in addressing the aforementioned clinical question and
support the EBP project. A PRISMA flow diagram depicting sources that were identified,
screened, and included in this project can be seen below in Figure 2.1.
The five databases were searched in a linear fashion, beginning with JBI. In JBI, a search
including “diabetes mellitus” OR “type 2” AND self-manag* with a 5-year limit (2016-current)
generated 58 results. Of the 58 results, five pieces of evidence were selected for use following
the screening of each and application of exclusion criteria. In Cochrane Library, a search
including the same keywords, Boolean operators, and limiters as those used within the JBI
database generated three results. None of these articles were deemed appropriate for use by the
project leader since they were focused on the pediatric population and other comorbidities. In
TRIP, a search including the keywords “diabetes mellitus” OR “type 2” AND manag* and limits of
5-years (since 2016) and guidelines generated 47 results. Of the 47 results, 4 pieces of evidence
were selected for use following the screening of each and application of exclusion criteria.
The search structure was then expanded to include an additional keyword and subject
heading in CINAHL and MEDLINE. The final search in these two databases which included the
exact major subject heading (MM “Diabetes Mellitus, Type 2”) AND self-care OR self-manag*
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AND “hemoglobin a1c” and limiters of 5-years (01/01/2016-12/31/2021), English language, and
scholarly (peer reviewed) journals generated 101 and 220 results, respectively. Of these results,
four articles were selected for use following the screening of each and application of exclusion
criteria. Following screening and application of inclusion and exclusion criteria, one additional
piece of evidence was selected for use by means of citation chasing by the project leader. A
PRISMA flow chart detailing the project leader’s method of screening and exclusion is depicted
below in Figure 2.1.

Figure 2.1
PRISMA Flow Diagram

Levels of Evidence
Sources were evaluated and leveled using Melnyk and Fineout-Overholt’s (2019)
Hierarchy of Evidence which has served as a guide to help determine types of research studies
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and reliability of evidence in order to answer a clinical question. Their hierarchy contains seven
levels, with Level I indicating the strongest evidence and Level VII indicating the weakest
evidence. Level I pieces of evidence include systematic reviews (SR) or evidence summaries
(ES) (Melnyk & Fineout-Overholt, 2019) and clinical practice guidelines (CPG) or consensus
statements (CS) (Melnyk, 2015). A SR or ES is a synthesis of multiple studies that addresses the
same research question (Melnyk & Fineout-Overholt, 2019). Clinical practice guidelines and
CSs, also commonly known as position statements, are carefully developed recommendations
for clinical practice based on evidence from SRs and evaluation of benefits and risks (Melnyk,
2015). Due to the prevalence of diabetes and numerous, available Level I studies involving this
diagnosis, only Level I pieces of evidence were selected for use in this EBP project: (a) four
CPGs, (b) one CS, (c) five SRs, and (d) four ESs. Table 2.1 depicts the author, database, and
level of evidence of each source.
Analysis and Appraisal of Relevant Evidence
Once each source’s level of evidence was determined, each source underwent a critical
analysis and appraisal by the project leader using the Johns Hopkins Nursing Evidence-Based
Practice (JHNEBP) Research and Non-Research Evidence Appraisal tools. Permission to use
these JHNEBP appraisal tools was received (see Appendix B). The JHNEBP appraisal tools
were used because they are well-known, widely accepted, easy to understand and follow, and
easily accessible. These appraisal tools aid in providing a quality rating ranked as high (A), good
(B), or low (C) (Dang et al., 2022). The CPGs and CS were appraised using the JHNEBP NonResearch Evidence Appraisal tool while the SRs and ESs were appraised using the JHNEBP
Research Evidence Appraisal tool. The overall assessment of the quality of evidence was
determined to be good to high. Of the 14 sources, 12 received a high (A) quality rating, and two
received a good (B) quality rating (see Table 2.1). A complete analysis and appraisal of each
piece of the evidence used in this EBP project are available for review in the Evidence Table in
Appendix C.
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Table 2.1
Summary of Evidence

Author/Year

Database(s)

Level of
Evidence/Type

Quality

Alexandre et al. (2021)

JBI

I/SR

High

Almutairi et al. (2020)

MEDLINE

I/SR

High

Baldoni et al. (2017)

MEDLINE

I/SR

High

Chrvala et al. (2016)

CINAHL
MEDLINE

I/SR

High

Garber et al. (2021)

TRIP

I/CS

Good

Khanh-Dao Le (2021a)

JBI

I/ES

High

Khan-Dao Le (2021b)

JBI

I/ES

High

Ombech (2021)

JBI

I/ES

High

Podder (2021)

JBI

I/ES

High

Pogach et al. (2017)

TRIP

I/CPG

High

Riddle et al. (2019)

Citation Chase

I/CPG

High

Sherifali et al. (2016)

CINAHL
MEDLINE

I/SR

High

Standiford et al. (2019)

TRIP

I/CPG

High

Waring et al. (2021)

TRIP

I/CPG

Good

Construction of Evidence-Based Practice
Synthesis of Critically Appraised Literature
To best address the clinical question, 14 relevant, high level, and good-high quality
pieces of evidence (Alexandre et al., 2021; Almutairi et al., 2020; Baldoni et al., 2017; Chrvala et
al., 2016; Garber et al., 2021; Khanh-Dao Le, 2021a&b; Ombech, 2021; Podder, 2021; Pogach
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et al., 2017; Riddle et al., 2019; Sherifali et al., 2016; Standiford et al., 2019; Waring et al., 2021)
were selected. During critical analysis, a primary theme associated with improved glycemic
control, or decreased HgbA1c levels, was DSM. Self-management involves all activities or
interventions in which a patient engages in order to care for their diabetes, expand diabetes
knowledge and resources, prevent short- or long-term negative effects from diabetes, and
promote overall health outcomes (Standiford et al., 2019). Furthermore, three key subtopics of
DSM were identified: (a) diabetes self-management education (DSME), (b) diabetes selfmanagement support (DSMS), and (c) DSM measurement.
Diabetes Self-Management Education
DSME may be delivered in various formats: (a) individual-based (Chrvala et al., 2016;
Khanh-Dao Le, 2021a&b; Podder, 2021; Pogach et al., 2017; Riddle et al., 2018), (b) groupbased (Baldoni et al., 2017; Chrvala et al., 2016; Khanh-Dao Le, 2021a&b; Podder, 2021;
Pogach et al., 2017; Riddle et al., 2019), or (c) combination of individual- and group-based
(Chrvala et al., 2016; Pogach et al., 2017). Khanh-Dao Le (2021a) and Podder (2021) reported
little to no differences in HgbA1c levels between group-based and individualized DSME at 24
months, but Khanh-Dao Le noted that attendance rates were low in group-based formats.
Interestingly, Chrvala and colleagues (2016) and Podder (2021) reported an overall mean
reduction in HgbA1c levels of 0.74 in all participants who participated in DSME. Regardless of
delivery format, DSME aimed at glycemic control included lifestyle changes primarily focused on
nutrition, physical activity, blood glucose monitoring, and medication adherence (Alexandre et al.,
2021; Almutairi et al., 2020; Garber et al., 2021; Khanh-Dao Le, 2021b; Pogach et al., 2017;
Riddle et al., 2019; Standiford et al., 2019; Waring et al., 2021).
Nutrition. Nutrition education should include healthy food choices (Riddle et al., 2019;
Waring et al., 2021), meal planning (Garber et al., 2020; Pogach et al., 2017; Riddle et al., 2019;
Standiford et al., 2019), portion control (Riddle et al., 2019; Standiford et al., 2019), and diet. The
incorporation of a low-carbohydrate Mediterranean (Pogach et al., 2017; Riddle et al., 2019;
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Waring et al., 2021) or typical low-carbohydrate (Riddle et al., 2019; Standiford et al., 2019) diet
has been demonstrated to improve glycemic control by decreasing HgbA1c levels; although, no
approach is reported to be superior to the other (Riddle et al., 2019). Barriers to healthy eating
include behavioral skills, demographics, environmental influences, and social or cultural factors
(Alexandre et al., 2021). For this reason, education on nutrition and diet should be individualized.
Physical Activity. Physical activity such as resistance (Riddle et al., 2019) and
moderate-intensity exercises (Waring et al., 2021) have been demonstrated to significantly
decrease HgbA1c levels. It is recommended that individuals undergo 30 minutes of aerobic
activity nearly every day with a minimum of 150 minutes of moderate-intensity activity each week
(Riddle et al., 2019; Garber et al., 2021; Waring et al., 2021). Similar to nutrition, barriers to
physical activity include behavioral skills, demographics, environmental influences, and social or
cultural factors (Alexandre et al., 2021). For this reason, physical activity should be individualized
and divided into increments as necessary (Riddle et al., 2019; Waring et al., 2021).
Blood Glucose Monitoring. While blood glucose monitoring is an important strategy in
DSM (Almutairi et al., 2020; Garber et al., 2021; Ombech, 2021; Pogach et al., 2017; Riddle et
al., 2019; Standiford et al., 2019; Waring et al., 2021) and reducing HgbA1c levels (Baldoni et al.,
2017; Ombech, 2021), routine, daily monitoring of blood glucose has often been reserved for
those on insulin (Garber et al., 2021; Pogach et al., 2017; Riddle et al., 2019; Standiford et al.,
2019; Waring et al., 2021). When necessary, blood glucose can be assessed through either self
or continuous monitoring, allowing for timely treatment or lifestyle changes based on the results
(Almutairi et al., 2020; Garber et al., 2021; Ombech, 2012; Riddle et al., 2019; Waring et al.,
2021). Blood glucose monitoring has demonstrated to improve glycemic control when the results
are used to make lifestyle changes (Waring et al., 2021). Similar to nutrition and physical activity,
barriers to blood glucose monitoring include behavioral skills, demographics, environmental
influences, and social or cultural factors (Alexandre et al., 2021) and should be considered when
determining a treatment plan.
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Medication Adherence. Medication adherence is an important strategy in DSM for
certain individuals who are unable to achieve glycemic control through lifestyle modifications
such as diet and physical activity (Almutairi et al., 2020; Garber et al., 2021; Khanh-Dao Le,
2021b; Riddle et al., 2019; Standiford et al., 2019; Waring et al., 2021). Riddle and colleagues
(2019) report poor medication-taking behaviors as an attributable factor to uncontrolled diabetes
in approximately 25% of diabetic patients. Similar to nutrition, physical activity, and bloodglucose monitoring, barriers to medication adherence include behavioral skills, demographics,
environmental influences, and social or cultural factors (Alexandre et al., 2021) and should be
considered when determining a treatment plan.
Diabetes Self-Management Support
DSMS, although a newer concept (Pogach et al., 2017), has demonstrated to significantly
improve glycemic control (Chrvala et al., 2016; Podder, 2021; Pogach et al., 2017; Riddle et al.,
2019; Sherifali et al., 2016). Similar to DSME, DSMS should be provided to patients in either an
individual- or group-format to help them successfully manage their diagnosis and perform
appropriate lifestyle changes (Pogach et al., 2017). DSMS is recommended by the evidence to
include goal setting (Chrvala et al., 2016; Khanh-Dao Le, 2021b; Riddle et al., 2019; Sherifali et
al., 2016; Standiford et al., 2019), empowerment (Almutairi et al., 2020; Baldoni et al., 2017;
Chrvala et al., 2016; Garber et al., 2020; Khanh-Dao Le, 2021b; Pogach et al., 2017; Riddle et
al., 2019; Sherifali et al., 2016; Standiford et al., 2019; Waring et al., 2021), and frequent followup (Almutairi et al., 2020; Baldoni et al., 2017; Garber et al., 2021; Khanh-Dao Le, 2021b;
Pogach et al., 2017; Riddle et al., 2019; Sherifali et al., 2016; Standiford et al., 2019; Waring et
al., 2021).
Goal Setting. Collaborative goal setting between the provider and patient is an important
strategy in DSMS and improving glycemic control (Chrvala et al., 2016; Khanh-Dao Le, 2021b;
Riddle et al., 2019; Sherifali et al., 2016; Standiford et al., 2019). Khanh-Dao Le (2021b) reported
a mean reduction in HgbA1c of 0.74 in patients using DSM interventions that were centered
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around goal setting. Goal setting provides an opportunity for patients to actively participate in
their own care and for healthcare providers to understand the needs of each patient (Khanh-Dao
Le, 2021b; Pogach et al., 2017) which allow for realistic and achievable goals to be established
(Alexandre et al., 2021). Approaches to goal setting should be closely aligned with DSM in an
effort to improve glycemic control and include individualized lifestyle modifications involving
nutrition, physical activity, blood glucose monitoring, or medication adherence (Chrvala et al.,
2016; Riddle et al., 2019; Sherifali et al., 2016). In addition to improving glycemic control (KhanhDao Le (2021b), collaborative goal setting promotes shared decision making and individualized,
patient centered care (Alexandre et al., 2021; Riddle et al., 2019; Sherifali et al., 2016).
Empowerment. Patient empowerment is an important strategy in DSMS (Alexandre et
al., 2021; Almutairi et al., 2020; Baldoni et al., 2017; Pogach et al., 2017; Riddle et al., 2019;
Sherifali et al., 2016; Standiford et al., 2019). Approaches to empowerment include shared
decision making (Alexandre et al., 2021; Riddle et al., 2019; Sherifali et al., 2016),
encouragement to accomplish goals directed towards DSM (Alexandre et al., 2021; Riddle et al.,
2019; Sherifali et al., 2016), and access to appropriate tools that are intended to help patients
integrate their goals into daily life, monitor progress, and achieve DSM (Alexandre et al., 2021;
Baldoni et al., 2017; Chrvala et al., 2016; Khanh-Dao Le, 2021b; Pogach et al., 2017; Riddle et
al., 2019; Standiford et al., 2019; Waring et al., 2021). Almutairi et al. (2020) and Baldoni et al.
(2017) reported similar results demonstrating significant reductions in HgbA1c levels following
the implementation of empowerment interventions. Additionally, empowerment has been shown
to improve patient knowledge and satisfaction of diabetes care (Pogach et al., 2017).
Follow-Up. Frequent follow-up by both patients (Chrvala et al., 2016; Pogach et al.,
2017; Riddle et al., 2019) and healthcare professionals (Almutairi et al., 2020; Chrvala et al.,
2016; Khanh-Dao Le, 2021b; Pogach et al., 2017; Riddle et al., 2019; Sherifali et al., 2016) is an
important strategy in achieving DSM. Patients who are newly diagnosed or have uncontrolled
diabetes should routinely be seen for follow-up every 3 months to evaluate HgbA1c levels and
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determine whether or not glycemic target goals have been achieved (Garber et al., 2021; Riddle
et al., 2019; Standiford et al., 2019; Waring et al., 2021). Improved rates of DSM and glycemic
control are attributed to frequent follow-up by healthcare professionals (Almutairi et al., 2020;
Khanh-Dao Le, 2021b; Pogach et al., 2017; Sherifali et al., 2016). In addition to in-person office
visits, DSM follow-up from healthcare professionals can occur remotely through the mail (Chrvala
et al., 2016) or by telephone (Almutairi et al., 2020; Pogach et al., 2017; Sherifali et al., 2016).
Frequent follow-up enables the provider to deliver ongoing support (Pogach et al., 2017), monitor
progress toward meeting previously set goals (Khanh-Dao Le, 2021b; Pogach et al., 2017),
establish new goals (Pogach et al., 2017), and re-educate patients on diabetes care as
necessary (Pogach et al., 2017).
Diabetes Self-Management Measurement
DSM is measured using various clinical biomarkers: (a) HgbA1c levels (Alexandre et al.,
2021; Almutairi et al., 2020; Baldoni et al., 2017; Chrvala et al., 2016; Garber et al., 2021; KhanhDao Le, 2021a&b; Ombech, 2021; Podder, 2021; Pogach et al., 2017; Riddle et al., 2019;
Sherifali et al., 2016; Standiford et al., 2019; Waring et al., 2021), (b) fasting blood sugar
(Podder, 2021), (c) blood pressure (BP) (Alexandre et al., 2021; Baldoni et al., 2017; Garber et
al., 2021; Pogach et al., 2017; Riddle et al., 2019; Standiford et al., 2019; Waring et al., 2021),
(d) lipid levels (Alexandre et al., 2021; Baldoni et al., 2017; Garber et al., 2021; Pogach et al.,
2017; Riddle et al., 2019; Waring et al., 2021), (e) BMI (Alexandre et al., 2021; Baldoni et al.,
2017; Riddle et al., 2019; Standiford et al., 2019), (f) weight (Garber et al., 2021; Pogach et al.,
2017; Riddle et al., 2019; Standiford et al., 2019; Waring et al., 2021), and (g) waist
circumference (Podder, 2021; Riddle et al., 2019). Measuring each of these biomarkers at each
diabetes follow-up is not considered practical or cost-effective. For this reason, HgbA1c levels,
BP, and weight or BMI are routinely measured at these visits (Garber et al., 2021; Pogach et al.,
2017; Riddle et al., 2019; Standiford et al., 2019; Waring et al., 2021). HgbA1c levels were the
primary outcomes measured across the studies to evaluate glycemic control (Alexandre et al.,
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2021; Almutairi et al., 2020; Baldoni et al., 2017; Chrvala et al., 2016; Khanh-Dao Le, 2021a&b;
Ombech, 2021; Podder, 2021; Sherifali et al., 2016) since it is considered to be the gold standard
measurement (Baldoni et al., 2017; Garber et al., 2021; Pogach et al., 2017; Riddle et al., 2019;
Standiford et al., 2019; Waring et al., 2021). In addition to biomarkers, psychosocial factors
(Khanh-Dao Le, 2021a&b) such as depression (Alexandre et al., 2021; Riddle et al., 2019) and
self-care (Alexandre et al., 2021; Riddle et al., 2019) are often measured using questionnaires.
The questionnaires utilized varied across the studies.
Recommendation for Best Practice
Current evidence supports the use of DSME and DSMS to improve glycemic control as
evidenced by a decrease in HgbA1c (Alexandre et al., 2012; Almutairi et al., 2020; Baldoni et al.,
2017; Chrvala et al., 2016; Garber et al., 2021; Khanh-Dao Le, 2021a&b; Ombech, 2021;
Podder, 2021; Pogach et al., 2017; Riddle et al., 2019; Sherifali et al., 2016; Standiford et al.,
2019; Waring et al., 2021). DSME centered on nutrition, physical activity, blood glucose
monitoring, and diabetes medication adherence have been demonstrated to significantly reduce
HgbA1c levels. Likewise, strategies of DSMS involving goal setting, empowerment, and frequent
follow-up by healthcare professionals have produced similar results.
Based on the evidence presented, one may propose that the best practice to improve
glycemic control by reducing HgbA1c levels would include a multimodal approach involving both
DSME and DSMS. Because diabetes affects individuals of all ages and requires a patient
centered approach, the most appropriate intervention to address the clinical problem of question
would be a universal, multimodal intervention: (a) goal setting, (b) educational supplements
about nutrition, physical activity, blood glucose monitoring, and medication adherence, (c) tools
intended to help patients integrate their goals into daily life, monitor progress, and achieve DSM,
and (d) frequent follow-up by a healthcare professional. Per best practice, the best proposed
outcome measurement to determine glycemic control is a HgbA1c level. This measurement is
easy to obtain, cost-effective, precise, accurate, and most importantly, supported by literature.
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A final literature search was conducted using the exact search structure listed above to
ensure that any significant literature published since the initial search were included. New Level I
pieces of evidence that were published after the implementation of this EBP project continue to
support the use of a multimodal intervention involving DSM in the form of DSME and DSMS, as
described above, in clinical practice (Bayuo, 2021; Minooee, 2021; Porritt, 2021; Richardson et
al., 2021).
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CHAPTER 3
IMPLEMENTATION OF PRACTICE CHANGE
Based on the statistical data and the supporting recommendations and evidence related
to T2D, the project leader developed a multimodal intervention involving goal setting, DSM
educational supplements and tools, and frequent follow-up to help improve glycemic control,
DSM behaviors, and overall health. First, participants, in collaboration with their family practice
provider or project leader, set individualized goals that were centered on lifestyle modifications
involving nutrition, physical activity, blood glucose monitoring, and/or medication adherence.
Second, participants were provided with a folder containing educational supplements and tools
centered around these lifestyle modifications that they could utilize as appropriate at home.
Third, participants received frequent follow-up by way of a reminder letter or progress telephone
call at 2, 4, and 8 weeks after enrolling in the project. Understanding that many participants may
have individualized limitations, the goal of this multimodal intervention was for it to be applicable
to all individuals across the lifespan who had T2D.
Participants and Setting
The EBP project took place at a rural family practice office in Northern Indiana. The key
stakeholders pertinent to the project included a family practice physician who had been
practicing for more than 10 years and a nurse practitioner who had been practicing for more than
22 years and served as the practice’s diabetic educator. At the time of this project, these
providers cared for more than 2,000 patients of all ages. Additional stakeholders included the
project leader and the practice’s medical assistants (MAs).
Individuals who were eligible to participate in the EBP project included those who were 18
years of age or older, had a diagnosis of T2D, were capable of reading and speaking English,
and desired to make or were willing to attempt at least one of the aforementioned lifestyle
modifications to achieve better glycemic control. Participants were required to read and speak
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English in order for them to read and understand the informed consent, questionnaires,
educational material and tools, and reminder letters as well as speak and understand the project
leader during the progress telephone calls. Additionally, participants needed to be due to have a
routine HgbA1c level checked at their initial visit prior to the start of the intervention and again in
12 weeks at the routine 3-month diabetes follow-up visit so that insurance would cover the cost
of the testing. Individuals who were considered to be a vulnerable population such as those
under the age of 18, pregnant women, prisoners, and cognitively impaired were excluded from
consideration for participation in the project.
Pre-Intervention Group Characteristics
The majority of participants consisted of older adults. Upon agreeing to volunteer in the
project at their initial visit, participants were asked to complete a form containing demographic
information (see Appendix D). The demographic information about the participants collected
included gender, age, ethnicity, highest level of education completed, current employment status,
current living arrangement, marital status, and number of years since diagnosis.
Intervention
Prior to implementing the intervention in the family practice setting, a substantial amount
of time went into planning the intervention, beginning with an exhaustive literature search that
served as the foundation of the EBP project. As noted previously, the evidence supported a
multimodal intervention aimed at DSM in the form of DSME and DSMS. Taking into account the
limitations of the site’s patient population including lack of internet access, transportation, and
financial resources, it was necessary for the EBP intervention to be easily accessible, cost
effective, and applicable for all T2D participants, regardless of their age. In coordination with the
literature, current recommendations, and preferences of the site’s diabetic educator, a
multimodal intervention was developed by the project leader.
The EBP project involved three essential interventions: (a) individualized goal setting that
was centered on DSM lifestyle choices involving nutrition, physical activity, blood glucose
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monitoring, and/or diabetes medication adherence by the participant under the guidance of their
family practice provider or project leader at their initial visit, (b) distribution of a folder containing
DSM educational supplements and tools which were to be used as appropriate by the participant
at home, and (c) frequent follow-up by the project leader in the form of two reminder letters at 2
and 8 weeks and one progress telephone call at 4 weeks.
Participants were recruited by their family practice provider or project leader at their
scheduled routine annual wellness or diabetes follow-up appointment to begin utilizing the
interventions of the EBP project. During this initial visit, participants were provided with verbal
and written information about the EBP project, signed an informed consent (see Appendix E),
had a HgbA1c level checked as it is routinely done at these visits, filled out a demographic form
and DSMQ (see Appendix D), set specific, measurable, attainable, realistic, and time-specific
(SMART) goals centered around nutrition, physical activity, blood glucose monitoring, or diabetes
medication adherence under the guidance of their family practice provider or project leader using
the SMART goals worksheet (see Appendix F), and received a folder containing DSM
educational materials and tools. Contents of the folder can be seen in Appendix G.
The project leader sent each participant a reminder letter and a new SMART goals
worksheet 2 and 8 weeks into the intervention which served as reminders to each of what their
SMART goal was, encouraged them to continue DSM efforts, and allowed them to make any
changes to their goals as they saw fit. The 2- and 8-week reminder letter templates can be seen
in Appendix H and I, respectively. Four weeks into the intervention, the project leader completed
a progress telephone call with each participant using a template as a guide (see Appendix J)
which allowed her to evaluate each participant’s progress, make note of any newly established
SMART goals, and provide encouragement to continue DSM efforts. If a participant did not
answer the initial progress telephone call, a voice message was left and a second call was made
approximately one week later. Participants then returned to the office for their scheduled routine
12-week diabetes follow-up appointments. At this appointment, a HgbA1c level was rechecked
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as it is routinely done at these visits and supported by EBP. Additionally, to complete the
intervention phase, participants filled out a final satisfaction questionnaire and DSMQ which was
either given to them in the office by the MAs or sent to them by mail by the project leader (see
Appendix K). Approval to use the DSMQ for this EBP project was received from Mapi Research
Trust (see Appendix L).
Comparison
During an in-depth chart review by the project leader, it was clear that prior to the
implementation of the multimodal intervention, diabetes management and treatment plans varied
between providers and were inconsistent between patients. The providers at this practice
themselves even voiced the need for a practice change implementation regarding management
of T2D, noting that this was an area for improvement.
Outcomes
During the course of the EBP project, two outcomes were evaluated: (a) glycemic control
and (b) DSM behaviors. The primary outcome evaluated was glycemic control, which was
measured by reviewing each participant’s pre- and post-intervention HgbA1c levels in their
electronic medical record (EMR). The secondary outcome evaluated was DSM behaviors which
was measured by the DSMQ prior to and following the intervention.
The data collected from reviewing each participant’s EMR included HgbA1c levels before
and after the implementation of the EBP project. POC HgbA1c levels are routinely performed by
the site’s MAs and nurses by obtaining a sample of the participant’s blood. The machine used to
run these tests is the Afinion AS 100 Analyzer by Abbott. Controls and the Abbott HBA1c
(HgbA1c) cartridges for this machine are checked routinely by the MAs and nurses. The project
leader reviewed the monthly log, control ranges, and expiration dates of the Abbott HBA1c
cartridges prior to the start of the EBP project on July 26th, 2021 and continued to do so routinely
throughout the course of the project’s implementation phase. Reliability and validity for the
Afinion AS 100 Analyzer by Abbott have been previously established (Jain et al., 2017). POC
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testing to measure HgbA1c has been routinely indicated for monitoring diabetes by the ADA and
has been demonstrated to have similar accuracy compared to clinical lab tests (Jain et al., 2017;
Szablowski et al., 2018).
The data collected from the pre- and post-intervention DSMQ included the frequency of
completing self-care activities related to DSM centered around nutrition/diet, physical activity,
blood glucose monitoring, and medication adherence. The DSMQ consists of 16 Likert scale
questions to which the participant would rate each question from 0 (does not apply to me) to 3
(applies to me very much). Reliability and validity for the DSMQ have been previously
established by its developer Schmitt et al. (2013), with reliability reported as an overall internal
consistency of 0.84 (Cronbach’s alpha).
Paired t-tests were used to compare pre- and post-intervention HgbA1c levels and DSMQ
scores.
Time
Implementation of the EBP project began in September 2021, coinciding with the
beginning of Valparaiso University’s fall semester. Prior to the implementation phase, the project
leader researched, developed, and organized the participant handouts and folders, created a
PowerPoint to inform the family practice providers of the EBP change (see Appendix M), applied
for institutional review board (IRB) approval, and completed more than 140 hours of project
development during the planning phase of the EBP project. Exemption from IRB approval from
both Valparaiso University and the project site was received. To protect the identity of the project
site, only Valparaiso University’s exemption is listed in Appendix N. The timeline necessary for
successful completion of the project by participants was 12 weeks as this allowed for appropriate
re-evaluation of HgbA1c levels as recommended by the ADA and AACE.
Thirty-three participants were recruited by either their family practice provider or the
project leader at their scheduled visit and began using the multimodal interventions during the
months of September, October, and November of 2021. The project leader performed frequent
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follow-up with each participant beginning the last week of September 2021. The participants
returned for their routine 12-week diabetes follow-up appointments beginning the first week of
December 2021. The project leader evaluated and recorded the coded data throughout the
course of the implementation phase from September 2021 through February 2022. The project
leader began to analyze the data in February and completed data analysis by the end of March
2022. The DNP manuscript detailing the project and its outcomes is expected to be published to
ValpoScholar during May 2022. A timeline of this EBP project can be seen on the
implementation timeline in Appendix O.
Protection of Human Subjects
A main priority of the project leader’s during this EBP project was the protection of human
subjects. All involved persons who actively participated in this EBP project had completed a
human subjects research training educational module within the past 2 years. To help protect the
identity of the project site, only the project leader’s ethics training certificate is listed in Appendix
P. The project leader completed the online training course through the Collaborative Institutional
Training Initiative Program on April 12, 2021. Approval to complete the EBP project was
submitted to the site’s organization and Valparaiso University’s IRBs prior to the implementation
of the project, and exemption was received on August 16, 2021 and August 18, 2021,
respectively. Participation in the EBP project was strictly voluntary and was indicated on the
informed consent which also specified that participants could discontinue participation at any
time. Individuals who chose not to participate in the project continued to receive the
recommended standard-of-care diabetic treatment by the family practice providers. Risks and
benefits of the project were discussed and detailed in the informed consent to promote selfdetermination.
Due to the nature of the EBP project involving frequent follow-up by the project leader,
complete confidentiality and anonymity of the participants during the implementation phase was
limited. It is important to note that there was no disclosure to anyone outside of the EBP project
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as disclosure only occurred among the project leader and practice’s providers and MAs.
Participants were aware of this and the steps taken to ensure their safety and privacy were
upheld throughout the duration of the project. Following completion by the participants, the
completed hardcopies of the informed consent, demographic form and DSMQ, SMART goals
worksheet, and follow-up satisfaction questionnaires containing any personal information were
initially stored by the family practice providers in a locked folder only accessible to them and the
project leader. Every week, the project leader retrieved and reviewed these hardcopies as well
as each participants HgbA1c level in their EMR, alone, on-site. Following review, any identifying
information listed on the hardcopies was coded and covered using a black sharpie, and the
hardcopies were stored on site using a double-locked, secured method until they were destroyed
by shredding following the completion of the project. The coded data was stored on an EXCEL
spreadsheet on the project leader’s personal USB drive utilizing a double password protected,
secured method until it was deleted following completion of the project in the presence of the site
facilitator. A list of patient names with corresponding codes was kept on a separate, doublepassword protected EXCEL sheet only available to the project leader.
Due to the nature of the project involving frequent follow-up with participants by way of
two mailed letters and one or two telephone call(s), limited available hours for the project leader
to be present on-site, and the participants having a preferred day and time to receive a progress
telephone call, the project leader completed the follow-up letters and telephone calls off-site. To
protect the participants’ personal information, each method of follow-up was completed in private
by the project leader following decoding of the necessary personal information, and any
identifying information was immediately deleted from both the project leader’s personal computer
or telephone upon completion of the follow-up. Data from the project was analyzed and shared
with others through the use of oral, written, and poster presentations; however, the project data
and site remained anonymous upon publication.
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CHAPTER 4
FINDINGS
The purpose of this patient-centered, EBP project was to evaluate the effectiveness of a
multimodal intervention involving goal setting, educational supplements and tools centered
around DSM, and frequent follow-up on HgbA1c levels and DSM behaviors. Specifically, this
project addressed the following PICOT question: In adults who have T2D (P), how does the
implementation of a multimodal intervention to encourage self-management (I) compared to
current practices (C) impact HgbA1c levels (O) over a 12-week period (T)?
The multimodal intervention was implemented among individuals who were over the age
of 18, had a diagnosis of T2D, and desired to make or were willing to attempt lifestyle changes
centered around diet, physical activity, blood glucose monitoring, and/or medication adherence in
order to achieve better glycemic control. Prior to and 12-weeks following the implementation of
the intervention, a HgbA1c level was checked and a DSMQ was administered. The primary
outcome demonstrated a reduction in mean HgbA1c levels from pre- to post-intervention.
Secondary outcomes demonstrated improvements in DSM behaviors related to diet, physical
activity, and blood glucose monitoring following implementation of the multimodal intervention.
Additional secondary outcomes demonstrated individual satisfaction with the intervention, and
participants reported helpfulness, benefit, and improved accountability as a result of the
intervention. Participants agreed that their providers should continue to use the multimodal
intervention with diabetic patients to encourage DSM in the future.
Participants
Thirty-three participants, 14 men (42.4%) and 19 women (57.6%), were recruited to
participate in the project. The attrition rate throughout the course of the implementation phase
was 9.1% (n = 3), with a total of 30 participants, 14 men (42.4%) and 16 women (48.5%),
returning for their final diabetes follow-up appointments. Of those lost to attrition, two participants
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received all parts of the intervention while one only received the folder containing DSM
educational materials and tools as this individual chose to discontinue participation shortly after
their initial visit. Attrition was due to travel, other health comorbidities, and illness.
The mean age of the pre-intervention and post-intervention groups was 62.9 and 63.4,
respectively. While the ages of participants ranged from 28 to 88 years for both groups, the
majority of participants consisted of older adults (see Appendix Q). Demographic characteristics
for both groups were analyzed by evaluating descriptive statistics (see Table 4.1 and Appendix
Q) and calculating a Pearson Chi-Square for each variable. Post-intervention characteristics did
not significantly differ from those initially recruited, and no significant relationships were found
between variables (p > .05).
Table 4.1
Participants’ Demographic Data

Pre-Intervention
n(%)

Gender
Male
Female

Mean(SD)

14(42.4)
19(57.6)

Age

Post-Intervention
n(%)

Mean(SD)

14(46.6)
16(53.4)
62.9(13.7)

63.4(13.9)

Ethnicity
White/Caucasian
Hispanic/Mexican

31(93.9)
2(6.1)

28(93.3)
2(6.7)

Education
Some HS*
HS Diploma/GED
Trade School
Associate’s Degree
Bachelor’s Degree
Master’s Degree
Doctorate Degree

4(12.1)
15(45.5)
7(21.2)
4(12.1)
1(3)
1(3)
1(3)

4(13.3)
13(43.3)
6(20)
4(13.3)
1(3.3)
1(3.3)
1(3.3)
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Employment*
Full-Time
Part-Time
Unemployed
Retired

9(27.3)
3(9.1)
1(3)
19(57.6)

9(27.3)
3(9.1)
17(51.5)

Living Arrangement
House
Apartment

31(93.9)
2(6.1)

29(96.7)
1(3.3)

Marital Status*
Single, Not Married
Married
Divorced
Widowed

4(12.1)
23(69.7)
1(3)
4(12.1)

4(13.8)
20(69)
1(3.5)
4(13.8)

Years Since Diagnosis*
Less than 1
1-2
3-5
6-10
11-20
21+

8(24.2)
2(6.1)
5(15.2)
8(24.2)
8(24.2)
1(3)

6(18.2)
2(6.1)
5(15.2)
8(24.2)
7(21.2)
1(3)

*Information missing from one participant, pre-intervention
Analysis of the Instrument
The DSMQ, which was administered prior to and 12 weeks following implementation of
the multimodal intervention, was used to measure participants’ self-perception of their DSM
behaviors over the previous 8 weeks. A Cronbach’s alpha was calculated to measure the internal
consistency of the 16 items within the DSMQ. The Cronbach’s alpha for the pre-intervention (n =
16), post-intervention (n = 16), and combined pre- and post-intervention (n = 32) DSMQs were α
= .749, α = .834, and α = .860, respectively. These results represent acceptable (.7 ≤ α < .8) and
good (.8 ≤ α < .9) internal consistency, demonstrating reliability of the DSMQ (Melnyk & FineoutOverholt, 2019).
Changes in Outcomes
Following implementation of the multimodal intervention and completion of data
collection, the primary and secondary outcomes of interest, HgbA1c levels and DSM behaviors,
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respectively, were evaluated. Additional secondary outcomes included satisfaction of the
multimodal intervention. The primary outcome demonstrated a reduction in mean HgbA1c levels
from pre- to post-intervention while secondary outcomes demonstrated improvements in DSM
behaviors related to diet, physical activity, and blood glucose monitoring.
Statistical Testing and Significance
All data were entered into International Business Machines Corporation’s (IBM’s)
Statistical Package for the Social Sciences (Version 25), also known as SPSS®, for analysis.
The project leader utilized the SPSS® step-by-step guide by Cronk (2020) to perform analysis
and interpret the results. The primary and secondary outcomes were evaluated using pairedsamples t tests. The primary outcome specifically addressed the aforementioned PICOT
question: In adults who have T2D (P), how does the implementation of a multimodal intervention
to encourage self-management (I) compared to current practices (C) impact HgbA1c levels (O)
over a 12-week period (T)? The paired-samples t tests compared the means of both pre- and
post-intervention HgbA1c levels and DSMQ scores. Descriptive statistics of both primary and
secondary outcomes were also evaluated in order to help further determine clinical and statistical
significance. The participants served as their own comparison for both the primary and
secondary outcomes.
Findings
The primary outcome of pre- and post-intervention HgbA1c levels was evaluated with a
paired-samples t test. The mean pre-intervention and post-intervention’s HgbA1c levels were
7.79% (SD = 1.28) and 7.69% (SD = 1.28), respectively, lacking statistical significance (t(30) =
0.59, p = .557) (see Table 4.2). Among all participants who completed the intervention (n = 30),
45% demonstrated lower post-intervention HgbA1c levels, supporting clinical significance for
these individuals (see Appendix R).
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Secondary Outcomes
Diabetes Self-Management Questionnaire. The secondary outcome of pre- and postintervention DSMQ scores was evaluated with a paired-samples t test. The DSMQ was scored
and analyzed in its entirety and then further broken down and scored into the following subcategories: (a) diet, (b) physical activity, (c) blood glucose monitoring, and (d) medication
adherence (see Appendix S). The mean pre-intervention and post-intervention total DSMQ
scores were 7.05 (SD = 1.39) and 7.54 (SD = 1.37), respectively, lacking statistical significance
(t(22) = -1.50, p = .148) (see Table 4.2). Among all participants who completed the DSMQ preand post-intervention (n = 22), 77% reported an increase in DSM behaviors, overall.
Diet. When establishing an initial SMART goal, 73.3% of participants (n = 22) centered
their goal around improving diet and nutrition (see Table 4.3 and Appendix T). The mean preintervention and post-intervention scores for diet within the DSMQ were 5.38 (SD = 2.12) and
5.95 (SD = 1.77), respectively, lacking statistical significance (t(22) = -1.37, p = .186) (see Table
4.2). Among all participants who completed the DSMQ pre- and post-intervention (n = 22), 50%
reported an improvement in DSM behaviors centered around diet.
Physical Activity. When establishing an initial SMART goal, 30% of participants (n = 9)
centered their goal around increasing physical activity (see Table 4.3 and Appendix T). The
mean pre-intervention and post-intervention scores for physical activity within the DSMQ were
6.99 (SD = 2.31) and 7.29 (SD = 1.65), respectively, lacking statistical significance (t(22) = -0.68,
p = .505) (see Table 4.2). Among all participants who completed the DSMQ pre- and postintervention (n = 22), 36% reported an improvement in DSM behaviors centered around physical
activity.
Blood Glucose Monitoring. When establishing an initial SMART goal, 23.3% of
participants (n = 7) centered their goal around improving blood glucose monitoring (see Table 4.3
and Appendix T). The mean pre-intervention and post-intervention scores for blood glucose
monitoring within the DSMQ were 4.77 (SD = 3.62) and 7.42 (SD = 2.83), respectively,

31
demonstrating statistical significance (t(22) = -3.18, p < .05) (see Table 4.2). Among all
participants who completed the DSMQ pre- and post-intervention (n = 22), 64% reported an
improvement in DSM behaviors centered around blood glucose monitoring.
Medication Adherence. When establishing an initial SMART goal, 6.7% of participants
(n = 2) centered their goal around improving diabetes medication adherence (see Table 4.3 and
Appendix T). The mean pre-intervention and post-intervention scores for medication adherence
within the DSMQ were 9.52 (SD = 1.50) and 9.20 (SD = 1.80), respectively, lacking statistical
significance (t(22) = 0.63, p = .538) (see Table 4.2). Among all participants who completed the
DSMQ pre- and post-intervention (n = 22), 10% reported an improvement in DSM behaviors
centered around medication adherence.
Intervention Satisfaction. The secondary outcomes of satisfaction with the multimodal
intervention were analyzed using descriptive statistics (see Table 4.4). Among all participants
who completed the intervention (n = 30), 73% (n = 22) completed the satisfaction questionnaire.
Of these participants, 100% (n = 22) reported satisfaction with the multimodal intervention.
Additionally, 90.9% (n = 20) of participants found the intervention to be helpful, 90.9% (n = 20)
found the SMART goals method easy to use, 95.5% (n = 21) found the DSM educational
materials and tools easy to read and understand, 90.9% (n = 20) found the DSM materials to be
beneficial, 95.5% (n = 21) found that frequent follow-up promoted accountability, and 95.5% (n =
21) recommended continued use of the multimodal intervention with future diabetic patients.
Clinical significance is further supported by multiple participants describing the intervention as
“life changing.” Most expressed sincere appreciation for this project and the inclusion of the DSM
educational materials, tools, and frequent follow-up. One described how he “found” himself again
and “got (his) life back.”
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Table 4.2
Primary & Secondary Outcomes: Paired-Samples t Tests

Total(n)

Mean(SD)

30
30

7.79(1.28)
7.69(1.28)

Pair 2: DSMQ (Total Score)
Pre-Intervention
22
Post-Intervention
22

7.05(1.39)
7.54(1.37)

Pair 3: Diet*
Pre-Intervention
Post-Intervention

22
22

5.38(2.12)
5.95(1.77)

Pair 4: Physical Activity*
Pre-Intervention
Post-Intervention

22
22

6.99(2.31)
7.29(1.65)

Pair 5: Blood Glucose*
Pre-Intervention
Post-Intervention

22
22

4.77(3.62)
7.42(2.83)

Pair 6: Med. Adherence
Pre-Intervention
Post-Intervention

22
22

9.52(1.50)
9.20(1.80)

Pair 1: HgbA1c
Pre-Intervention
Post-Intervention

t value

p value

0.59

.557

-1.50

.148

-1.37

.186

-0.68

.505

-3.18

.004

0.63

.538
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Table 4.3
SMART Goals

N(%)

Diet/Nutrition
Yes
No

22(73.3)
8(26.7)

Physical Activity
Yes
No

9(30)
21(70)

Blood Glucose Monitoring
Yes
No

7(23.3)
23(76.7)

Medication Adherence
Yes
No

2(6.7)
28(93.3)
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Table 4.4
Satisfaction with Intervention

N(%)

Satisfaction with Intervention
Yes
No

22(100)
-

Intervention was Helpful
Yes
No
Missing

20(90.9)
1(4.5)
1(4.5)

SMART Method Easy to Use
Yes
No
Missing

20(90.9)
2(9.1)

DSM Materials Easy to Read/Understand
Yes
21(95.5)
No
Missing
1(4.5)
DSM Materials Beneficial
Yes
No
Missing

20(90.9)
2(9.1)

Frequent Follow-up Promoted Accountability
Yes
21(95.5)
No
Missing
1(4.5)
Recommend Continued Use of Intervention
Yes
21(95.5)
No
Missing
1(4.5)
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CHAPTER 5
DISCUSSION
The goal of this project was to determine if the implementation of a multimodal
intervention involving individualized goal setting, educational supplements and tools centered
around DSM, and frequent follow-up improves HgbA1c levels and DSM behaviors in patients
with T2D. When developing treatment plans for diabetic patients, the doctoral-prepared
advanced practice registered nurse (APRN) understands the importance of taking into account
the limitations of the site’s patient population including but not limited to lack of internet access,
transportation, and financial resources. For this reason, it was necessary for this EBP
intervention to be easily accessible, cost effective, and applicable for all T2D participants,
regardless of their age. In coordination with the literature, current evidence, and professional
organizations’ recommendations, the primary outcome of interest, HgbA1c levels, was chosen
because this testing is routinely performed to evaluate glycemic control at each patient’s
diabetes follow-up appointment. The goal of the primary outcome of decreased HgbA1c levels
would help decrease the risk of developing major health problems and improve overall health.
This chapter will provide an explanation and interpretation of project findings, discussion of
strengths and limitations of the EBP project, examination of relevance of the EBP model, and
recommendations for future EBP projects and clinical practice.
Explanation of Findings
Primary Outcome
The primary outcome of the project did not result in a significant decrease in HgbA1c
levels (t(30) = .59, p = .557). While the mean pre-intervention and post-intervention HgbA1c
levels demonstrated only a 1.28% reduction rate, 45% of participants (n = 14) demonstrated a
reduction rate ranging from 1.66% to 25.89%. In terms of HgbA1c levels, 10% of participants (n =
3) who demonstrated poorly controlled diabetes prior to the intervention experienced greater
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than 1% decrease in their HgbA1c level, superseding the mean reduction of 0.74% reported in
the study by Chrvala et al. (2016) and similar findings by Almutairi and colleagues (2020). Ten
participants’ HgbA1c levels (30%) dropped or remained below the target goal of 7% as
recommended by Garber et al. (2020), Pogach et al. (2017), Riddle et al. (2019), Standiford et al.
(2019), and Waring et al. (2021). Additionally, 30% of participants (n = 10) demonstrated a
clinically significant decrease in HgbA1c levels as evidenced by a decrease in HgbA1c level by ≥
0.5% (Lisi, 2018). The primary outcome results, both the lack of overall statistical significance
and achievement of clinical significance for some participants, are best supported when viewed
within the context of the secondary outcomes which are discussed below.
Secondary Outcomes
The EBP project involved three essential interventions of which DSM lifestyle
modifications involving diet and nutrition, physical activity, blood glucose monitoring, and/or
diabetes medication adherence served as the foundation of the project. To best assess changes
in these lifestyle behaviors and their influence on the primary outcome, total scores of the DSMQ
and subcategories of diet, physical activity, blood glucose monitoring, and medication adherence
were analyzed.
Diabetes Self-Management Questionnaire
As noted previously, among all participants who completed the DSMQ pre- and postintervention (n = 22), 77% reported an increase in DSM behaviors, overall. Furthermore, greater
than 81% reported an improvement in one or more of the four focused lifestyle modifications.
Similarly, Almutairi and colleagues (2020) reported an improvement in at least one DSM
behavior for all RCTs involved in their study.
Diet. Diet, along with physical activity, was the most commonly measured DSM behavior
in the RCTs addressed by Almutairi et al. (2020). Similarly, the majority of participants involved in
this EBP project (73.3%) centered their goal around improving diet and nutrition as this provided
more realistic and achievable opportunities for most. Common, specific yet individualized goals
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included meal planning, portion control, decreasing carb intake, replacing high starchy foods with
vegetables, and avoiding sweets. These goals similarly reflect Standiford and colleagues’ (2019)
recommendations to include portion control, healthy choices, and monitoring carb intake when
meal planning. Statistical significance was not achieved in this area as evidenced by the mean
pre- and post-intervention scores of 5.38 (SD = 2.12) and 5.95 (SD = 1.77). However, among all
participants who completed the DSMQ pre- and post-intervention (n = 22), 50% reported an
improvement in DSM behaviors centered around diet. In addition to setting an individualized
goal, this improvement may be attributable to both the reinforcement of the importance of diet
and nutrition in diabetes outcomes and frequent follow-up which was reported by participants to
promote accountability. Standiford et al. (2019) emphasizes the need to reinforce appropriate
diet at every visit and during every patient encounter. Khanh-Dao Le (2021a) notes significant
improvements in HgbA1c levels and DSM behaviors in those in which individualized telephone
and mailing interventions were implemented. Additional evidence supports interventions aimed at
impacting individual diet and nutrition as a critical component of DSME and DSMS for those with
T2D (Khanh-Dao Le, 2021a).
Physical Activity. Physical activity, along with diet, was the most commonly measured
DSM behavior in the RCTs addressed by Almutairi et al. (2020). Many participants involved in
this EBP project (30%) centered their goal around increasing physical activity as this provided
more realistic and achievable opportunities for many. Statistical significance was not achieved in
this area as evidenced by the mean pre- and post-intervention scores of 6.99 (SD = 2.31) and
7.29 (SD = 1.65), respectively. However, among all participants who completed the DSMQ preand post-intervention (n = 22), 36% reported an improvement in DSM behaviors centered around
physical activity. In addition to setting an individualized goal, this improvement may be
attributable to both the reinforcement of the importance of physical activity in diabetes outcomes
and frequent follow-up which was reported by participants to promote accountability. Standiford
et al. (2019) emphasizes the need to reinforce physical activity at every visit and with every
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patient encounter. Again, Khanh-Dao Le (2021a) notes significant improvements in HgbA1c
levels and behaviors in those in which individualized telephone and mailing interventions were
implemented.
Blood Glucose Monitoring. Few participants involved in this EBP project (23.3%)
centered their goal around increasing blood glucose monitoring as this provided more realistic
and achievable opportunities for some. Statistical significance was achieved in this area as
evidenced by the mean pre- and post-intervention scores of 4.77 (SD = 3.62) and 7.42 (SD =
2.83), respectively. Among all participants who completed the DSMQ pre- and post-intervention
(n = 22), 64% reported an improvement in DSM behaviors centered around blood glucose
monitoring. In addition to setting an individualized goal, this improvement may be attributable to
the frequent follow-up which was reported by participants to promote accountability. Multiple
participants were started on continuous glucose monitoring (CGM) during the implementation of
the project. This likely significantly impacted these results. Ombech (2021) reports reductions in
HgbA1c levels regardless of the method utilized to self-monitor blood glucose. By monitoring
blood glucose levels, participants reported being able to make better choices related to diet,
physical activity, and medication adherence. This further supports Waring and colleagues’ (2021)
recommendation that self-monitoring of blood glucose demonstrates benefit when the results are
used to make lifestyle changes or adjustments.
Medication Adherence. Very few participants involved in this EBP project (6.7%)
centered their goal around improving diabetes medication adherence. Statistical significance was
not achieved in this area as evidenced by the mean pre- and post-intervention scores of 9.52
(SD = 1.50) and 9.20 (SD = 1.80), respectively. Among all participants who completed the DSMQ
pre- and post-intervention (n = 22), 10% reported an improvement in DSM behaviors centered
around medication adherence. Based on the mean scores and associated standard deviations,
one could state that medication adherence remained about the same, lacking improvement or
worsening behavior, regardless of the intervention. Alexandre and colleagues (2021) identified
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many demographic, psychological, and physical barriers of DSM related to medication
adherence: (a) low socioeconomic position resulting in personal financial constraints and lack of
access to medication, (b) forgetting to take diabetes medication resulting in missed doses, and
(c) anxiety about side effects. Similar findings from this project included personal financial
constraints and high costs of the medication which were not covered by insurance despite prior
authorizations, lack of access to medication for other reasons, forgetting to take the medication,
and medication side effects.
Satisfaction Questionnaire
Among all participants who completed the intervention (n = 30), 73% (n = 22) completed
the satisfaction questionnaire. Of these participants, 100% (n = 22) reported satisfaction with the
multimodal intervention. Additionally, 90.9% (n = 20) of participants found the intervention to be
helpful, 90.9% (n = 20) found the SMART goals method easy to use, 95.5% (n = 21) found the
DSM educational materials and tools easy to read and understand, 90.9% (n = 20) found the
DSM materials to be beneficial, 95.5% (n = 21) found that frequent follow-up promoted
accountability, and 95.5% (n = 21) recommended continued use of the multimodal intervention
with future diabetic patients. Clinical significance is further supported by multiple participants
describing the intervention as “life changing.” Most expressed sincere appreciation for this
project and the inclusion of the DSM educational materials, tools, and frequent follow-up. One
described how he “found” himself again and “got (his) life back.”
Overall results of this EBP project compared to previous studies may be negatively
influenced by the duration of the project. The length of the interventions intended to improve
glycemic control and DSM behaviors varied among the studies by Almutairi et al. (2020), Baldoni
et al. (2017), and Podder (2021), ranging from 3 months to 2 years. The duration of this project
was 12 weeks. During the evaluation phase of the project, the project leader continued to follow
many participants during a separate clinical experience. Most of the participants demonstrated
new or further reductions in HgbA1c levels which could not be included in the data for this project
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since this project was evaluating the intervention for only 12-weeks, and completion of data
analysis was required at an earlier date compared to when the participants were seen again.
Strengths and Limitations of the DNP Project
Strengths
Many strengths related to the project site were identified throughout each phase of
planning, implementation, and evaluation of the EBP project. Perhaps the biggest and most
important one being the support and willingness of the agency and medical director to allow
implementation of an EBP change. At first mention of a DNP project, the providers discussed
among themselves about what improvements in patient outcomes were needing to be made at
this site. This allowed clear guidance for the project leader as to what patient population to focus
on. Initial interest was placed on implementing CGM. However, once it was determined by the
project leader that this was not a feasible intervention due to few patients meeting the criteria for
CGM and cost of the intervention, the providers at this site were willing to allow the project leader
to change the direction of the intervention. While CGM was not the project intervention, the
providers did begin providing those who met the criteria with a sample of a 2-week CGM system
as well as prescribing these systems more frequently which likely contributed to increased blood
glucose monitoring behaviors and achievement of statistical significance. The diabetic educator
played a vital role in not only supporting this project through excitement but also identifying
patients who were interested in participating for recruitment by the project leader. The number of
diabetic patients seen at the project site contributed to a good recruitment rate of 33 participants
within 2 months. The project site was open daily throughout the week, allowing the project leader
to work on and complete each phase of the project at her convenience. All of the staff, in addition
to the agency’s providers, were very supportive, allowing for timely implementation and
completion of the project.
Strengths related to the multimodal intervention included overcoming limitations of the
patient population which included lack of internet access, transportation, and financial resources.
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Participants were recruited, set individualized goals, and given the DSM folder at their already
scheduled appointments. Contents of the DSM folder were easy to read and understand. Initial
hesitancy of participation was addressed when participants were informed that the intervention
was free, they did not need internet access, and only needed to return to the office for their next
3-month diabetes follow-up appointment since follow-up by the project leader was completed by
both mail and telephone. Costs of the intervention, initially covered by the project leader, were in
turn covered by a grant from Sigma Theta Tau Zeta Epsilon chapter during the phase of
implementation.
Limitations
Perhaps the largest, yet expected, barriers of the project, likely preventing the
achievement of statistical significance, were the patient identified limitations associated with the
holidays (Thanksgiving, Christmas, and New Year’s), weather, and illness. As noted previously,
the majority of participants centered their DSM goal around diet. Upon return to their 3-month
follow-up appointments, more than 30% of participants made mention of struggling with diet
around the holidays. Poor weather conditions made it difficult for many to increase their physical
activity. Many stated they were unable to get outside due to the cold, snow, or rain. Furthermore,
few reported that the weather influenced their mood and motivation, or lack thereof. Last, illness
related to Covid-19, pneumonia, and additional health complications, including surgery,
negatively impacted participants’ ability to work towards achieving their goals. Additional
participant associated barriers encountered in the project, similar to those identified in the study
by Alexandre et al. (2021), included financial constraints. Participants voiced an inability to afford
healthier eating options or medications as well as the need to work long hours, both of which
inhibited their efforts towards improving glycemic control, DSM behaviors, and overall health.
An aforementioned strength also served as a limitation to the project: the inability to
implement CGM as the project intervention. While very supportive in other ways, the energy of
one key stakeholder and desire to implement the multimodal intervention decreased when it was
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determined that CGM was not a feasible intervention for the project. This resulted in a very low
recruitment rate by the provider, and many diabetic patients missed the opportunity to participate
in the project. Additionally, although multiple efforts, including the development of an informative
PowerPoint and quick facts note sheet, were taken by the project leader to inform all providers
about the intervention and pertinent information related to its’ implementation, there was
confusion about who could participate in the project, initially. This also resulted in many diabetic
patients missing the opportunity to participate in the project.
Additional limitations that occurred early on during the implementation phase and were
not anticipated included the time it took to recruit participants and complete the initial visit and
underutilization of the SMART goals method by the providers. It is likely that these two limitations
were closely related. To combat these limitations, the project leader remained on-site and
assumed responsibility of recruitment once patients who were willing to participate in the project
were identified by their provider. By doing this, the project leader was able to spend the
necessary amount of time with each participant explaining the interventions, setting SMART
goals, and answering questions. Last, an unanticipated limitation was the inability to be on-site
during the weeks of Valparaiso University’s academic break and between semesters to ensure
the final questionnaires were being administered to each participant upon return to their 3-month
diabetes follow-up appointment. Prior to the break, the project site’s staff were given a list of
days in which participants would be returning for their follow-up appointments. To help improve
the response rate upon return to the site following break, the project leader mailed the
questionnaire and an appreciation letter (see Appendix U), along with a pre-addressed stamped
envelope, to those who were not administered a questionnaire at their follow-up appointment.
Sustainability
To help promote sustainability of the intervention, the project leader provided the site
with extra DSM folders which also contained the SMART goals worksheet. Most of the content
included in the DSM folder were free, downloadable, and reproducible handouts from the
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American Diabetes Association and can be easily accessed online (see Appendix G).
Additionally, the weekly log and journal (see Appendix G), which were created by the project
leader, were given to the diabetic educator to print out as needed. Ways to continue similar
frequent follow-up with diabetic patients were discussed, but did not result in a set plan as this
will require further effort from management and other support staff. This EBP change will likely
be adopted by certain providers of the practice as they are planning to hire on an additional
provider who is also passionate about diabetes and interested in implementing this intervention.
Recommendations for future implementation and sustainability of the multimodal intervention
would include implementing the project during the spring or summer months to help aid patients
in establishing healthy DSM behaviors and habits prior to the holidays and winter months.
Relevance for EBP Model
The Iowa Model Revised served as a guide in the development, implementation, and
evaluation of this EBP project. The model’s sevens steps closely aligned with the project: (1)
identifying triggering issues or opportunities, (2) stating the question or purpose, (3) forming a
team, (4) assembling and synthesizing the body of evidence, (5) designing and piloting the
practice change, (6) integrating and sustaining the practice change, and (7) disseminating the
results (Buckwalter et al., 2017; Dang et al., 2019). The three decision points, located at the end
of steps 2, 4, and 5, aided the project leader in determining topic priority, sufficiency of evidence,
and appropriateness of EBP change. These decision points were pertinent to this project as they
provided feedback loops throughout allowing the project leader to revisit previous steps as
necessary.
Together, the providers at the project site identified an area in which patient outcomes
needed improvement: diabetes (step 1). The project leader then developed an initial PICOT
question centered around CGM (step 2). Before moving forward, it was necessary to determine
whether or not this topic was a priority (decision point 1). Due to related costs and unmet criteria,
CGM was not deemed a priority resulting in the project leader to enter the feedback loop and
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revisit the previous step. From there a new PICOT question was formed and priority was
established. To achieve appropriate use of everyone’s time, evidence assembly, appraisal, and
synthesizing (step 4) and determination of sufficient evidence (decision point 2) were completed
prior to forming a team involving the diabetic educator and other key stakeholders (step 3). The
EBP multimodal intervention was developed and implemented, and data were evaluated (step 5).
Based on its’ clinical significance, it has been determined that this EBP change is appropriate for
adoption into practice (decision point 3). Discussion of how to sustain the practice change is
ongoing (step 6). The results of the project were disseminated to the project site’s providers and
at the University of Iowa Hospitals & Clinics 29ths National EBP Conference (step 7).
As noted above, it was necessary that steps 3 and 4 be switched for this project. The
steps, decision points, and feedback loops within the model support its ease of use and
applicability in the clinical setting. The Iowa Model Revised allowed the project leader to
establish clear boundaries, set an appropriate target, and utilize a more focused approach to
help achieve successful EBP change (Buckwalter et al., 2017; Dang et al., 2019). This model
supported the engagement of patients as key stakeholders, the incorporation of patient
preferences and values, and the consideration of the patient-partnership as an ongoing priority.
The use of the Iowa Model Revised was appropriate for this EBP project because of its emphasis
on patient-centeredness and the structure of its framework.
Recommendations for the Future
The incidence of diabetes continues to increase at an alarming rate (WHO, 2020). Each
year, there are 1.5 million newly diagnosed cases of diabetes each year in the U.S. (CDC,
2020c). This condition affects individuals of all ages and leads to increasing morbidity and
mortality. Results from this EBP project support recommendations for future research and
practice by the doctoral-prepared APRN.
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Research
Future research is needed to determine if the multimodal intervention impacts long-term
diabetes outcomes and overall health. The overall results of this EBP project compared to
previous studies may be negatively influenced by duration of the project. As noted previously, the
length of the interventions intended to improve glycemic control and DSM behaviors varied
among the studies by Almutairi et al. (2020), Baldoni et al. (2017), and Podder (2021), ranging
from 3 months to 2 years in duration. The duration of this project was only 12 weeks.
Additionally, future research is needed to determine if the multimodal intervention is more
effective and sustainable for patients if implemented during the spring or summer months.
Diabetic patients may be able to establish better habits and experience better results and
sustainability during the spring and summer months because the weather is nice and there is
often easier access to fruits and vegetables in the Midwest regions of the U.S. The limitations
listed above demonstrate that future research is needed to determine how to best help patients
manage their diabetes during the winter months and increase DSM motivation over the holiday
seasons. Last, future research is needed to determine whether or not CGM impacts long-term
diabetes outcomes and overall health for all T2D patients which may support changes to the
current criteria required to prescribe CGM.
Practice
The clinical findings of this EBP project may support the APRN’s use of a multimodal
intervention in the treatment plan of a patient with T2D. The findings indicate that a multimodal
intervention is not only effective in reducing HgbA1c levels but also increasing DSM behaviors in
many patients with T2D. Both quantitative and qualitative data support the continued use of
DSME and DSMS.
Education
Although a very common diagnosis, little is known about diabetes in the clinical setting.
Unfortunately, the undesired outcomes related to diabetes are broad and often vary between
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individuals. Many are uninformed about the negative and positive influences that lifestyle habits
and behaviors can have on their diabetes and overall health. In a high technological, fast paced
world, managing diabetes is simple. It truly is all about getting back to the basics: (a) diet, (b)
physical activity, (c) blood glucose monitoring, and (d) medication adherence. This should be
emphasized not only in the clinical setting by providers to their patients but also in the
educational setting by professors to their students who are in medical training. Knowledge is
power. It is up to each provider that their diabetic patients are both properly informed about the
measures one can take to improve glycemic control and DSM behaviors and equipped with the
tools to achieve success.
Conclusion
The purpose of this EBP project was provide primary care APRNs and their physician
counterparts with interventions that are easily accessible, cost effective, and applicable for all
T2D patients to improve diabetes outcomes and overall health. Specifically, the goal of the
multimodal intervention involving goal setting, DSM educational materials and tools, and frequent
follow-up was to decrease HgbA1c levels and improve DSM behaviors. By utilizing the
intervention, 30% of participants’ HgbA1c levels dropped or remained below the target goal of
7%, and 30% demonstrated a clinically significant decrease in HgbA1c level as evidenced by a
decrease in HgbA1c level by ≥ 0.5%. Self-management behaviors centered around diet, physical
activity, blood glucose monitoring, and medication adherence increased by 77%. Participants
reported 100% satisfaction with the intervention and recommended that their providers continue
its use with future diabetic patients. It is the responsibility of the APRN provider to ensure their
patients are both properly informed about the measures one can take to improve glycemic
control and DSM behaviors and equipped with the tools to achieve DSM success. In a high
technological, fast paced world, managing diabetes is simple. It truly is all about getting back to
the basics: (a) diet, (b) physical activity, (c) blood glucose monitoring, and (d) medication
adherence.
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APPENDIX A
Literature Search Grid
Database/Resource
Searched

Keywords/Phrases
Used

Limiters
Used

Number of
Results
from Search

Number of Pieces of
Evidence Selected for
Use
In Paper

Joanna Briggs Institute
EBP Database (JBI)

“Diabetes Mellitus” OR “Type 2”
AND Self-manag*

5 year limit (2016-current)

58

5

Cochrane Library

“Diabetes Mellitus” OR “Type 2”
AND Self-manag*

5 year limit (Jan 2016 to Jun
2021)

3

0

Turning Research into
Practice (TRIP) Medical
Database
CINAHL

(Title: “Diabetes Mellitus” OR “Type 2”)
AND Manag*

Guidelines
5 year limit (from:2016)

47

4

(MM "Diabetes Mellitus, Type 2")
AND self-care OR self-manag*
AND "hemoglobin a1c"

101

2

MEDLINE with Full Text
(via EBSCO)

(MM "Diabetes Mellitus, Type 2")
AND self-care OR self-manag*
AND "hemoglobin a1c"

Published Date: 2016/01/012021/12/31
English Language
Scholarly (Peer Reviewed)
Journals
Date of Publication:
2016/01/01-2021/12/31
English Language
Scholarly (Peer Reviewed)
Journals

220

2

List the Title of the Article/Original
Piece of Evidence that contained
the “Citations Chased”
Pieces of Evidence
selected that were
“Citation Chased”
from systematic
reviews, evidence
summaries,
guidelines, etc.

Number of
Pieces
Searched

Number of New Pieces
of “Chased” Evidence
Selected for Use

Factors Influencing Diabetes Self-Management
in Adults: An Umbrella Review of Systematic
Reviews
Diabetes (Non-Hospitalized Patient): Selfmanagement Education

N/A

6

1

N/A

1

0

Diabetes (Self-Managed Type 2): Educational
Support in Community Settings

N/A

1

0

Blood Glucose Level: Self-Monitoring

N/A

1

0
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Management of Type 2 Diabetes Mellitus

N/A

1

0

American Diabetes Association Standards of
Medical Care in Diabetes - 2019

N/A

1

0

VA/DoD Clinical Practice Guideline for the
Management of Type 2 Diabetes Mellitus in
Primary Care

N/A

2

0

Total Number of pieces of Evidence
Identified for Use:

14
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APPENDIX C
Table 2.2
Evidence Table
Lead Author/
Year/Quality

Purpose/
Design/Sample
or Population

Interventions

Measurement/
Outcomes

Results/
Findings

Strengths/
Limitations

Level I Evidence
Alexandre, K.
(et al.)
2021

Purpose: To
determine what
factors influence
diabetes selfmanagement

High Quality (A)
Design: Systematic
review
Sample: Adults
diagnosed with
either type I or type
II diabetes mellitus
114 systematic
reviews were
included in this
systematic review
sample.

Almutairi, N.
(et al.)
2020
High Quality (A)

There were multiple
countries of origin
involved in all of the
studies combined.
Purpose: To
determine the
effectiveness of
“patient activation
intervention” on
glycemic control and

There were no isolated
interventions specific to this
review. This systematic
review is an umbrella
review of 114 systematic
reviews combined. Each of
these systematic reviews
focused on various
diabetes self-management
foci: DSM motivational
predictors, DSM adherence
factors, self-care activities,
cost of care associated
with DSM, social/peer
support,

Barriers or facilitators of
diabetes self-management
Diabetes selfmanagement/Individual
behaviors/factors
Hemoglobin A1c, blood
pressure (diastolic and
systolic), Lipid panels,
smoking cessation, BMI,
depression scores, social
support, self-care

There were approximately 40
factors related to diabetes selfmanagement identified.
Psychological factors are one of
the most common barrier or
facilitator of diabetes selfmanagement. Additional barriers
or facilitators are behavioral skills,
demographics, physical
environment, and social or cultural
influencers.
Most commonly studied DSM
behaviors are diet, physical
activity, and medication
compliance.

Strengths:
Authors
addressed
heterogeneity of
the included
studies. Authors
included strong
sample and
population
Limitations:
Layout of SR
was difficult to
follow. Lacks
statistical
conclusions

Diet, physical activity,
Medication adherence,
self-monitoring of blood
glucose, depression,
cognitive behavioral
therapy (CBT), foot care,

Patient activation is a
concept focused on
“patient knowledge, skills
and confidence building”
(p. 17).

Glycemic control
(hemoglobin A1c levels) and
diabetes self-management
behaviors were measured
as either the primary or

7 of the 10 studies reported a
significant improvement in
glycemic control for the
intervention group.

Strengths:
Search strategy
provided along
with PRISMA;
Inclusion and
Exclusion

60
diabetes selfmanagement
behaviors (p. 13)
Design: Systematic
review
Sample: Adults
(greater than 18
years of age) who
have type 2 diabetes
mellitus
10 RCTs with a total
of 3,728 participants
were included in this
systematic review

Baldoni, N. R.
(et al.)
2017
High Quality (A)

There were multiple
countries of origin
involved in all of the
studies combined:
U.S (4), Chine (2),
Brazil (1), United
Kingdom (1),
Germany (1), and
Qatar (1).
Purpose: To
determine the
effectiveness of
empowerment
strategies on
hemoglobin A1c
levels in patients
who have diabetes
mellitus.
Design: Systematic
review with metaanalysis
Sample: Individuals
who have diabetes
mellitus (type 1 or
2). The majority of

The RCTs in this
systematic review utilized
multiple patient activation
interventions (motivational
interviewing, patient
empowerment,
individualized patient
centered care, skills
building, etc.).

secondary outcome(s) in all
10 studies.
Self-management behaviors
include: diet, physical
activity, blood glucose
monitoring, medication
compliance, and foot care.

The interventions were
delivered by way of inperson, telecare (including
telephone calls/follow-up),
and a combination of the
two.

Those who had very poorly
controlled diabetes (starting
hemoglobin A1c greater than
10%) demonstrated a significant
decrease with the intervention.

Criteria;
Information of
each study
provided clearly
on tables

All RCTs reported an
improvement in at least 1
diabetes-self management
behavior for the intervention
group.

Limitations:
None Identified

Diet and physical activity were the
most commonly measured selfmanagement behavior.

The intervention ranged
from 6 weeks to 1 year.

The interventions consisted
of empowerment strategies
and varied between
studies: group discussion,
diabetes education toolkits,
self-care booklets centered
on diabetes, weekly
meetings, etc.

Hemoglobin A1c was utilized
as the gold standard
measurement and primary
outcome for glycemic control
evaluation and effectiveness
of the intervention.
Additional outcomes were
measured: diastolic blood
pressure, lipid levels, diet,
blood glucose monitoring,
BMI, attitudes toward
diagnosis, and confidence of
knowledge of diagnosis

6 of the 9 studies demonstrated a
significant reduction in
hemoglobin A1c levels for the
intervention groups.

Strengths:
Appropriate
search strategy
provided along
with PRISMA.
Tables provided
are easy to follow
and detail each
study
Limitations:
None identified

61
the studies included
only patients with
type 2.
9 studies taking
place in various
countries were
included in this
systematic review; 7
of the 9 studies were
included in the metaanalysis

Chrvala, C. A.
(et al.)
2016
High Quality (A)

Sample sizes of
each study ranged
from 32 to 430
participants
Purpose: To
determine the
effectiveness of
diabetes selfmanagement (and
mode of delivery,
provider type, and
duration) and
support on
hemoglobin A1c
levels in adults who
have type 2diabetes
mellitus.
Design: Systematic
review
Sample: Adults who
have type 2 diabetes
(studies may have
included both type 1
and 2 – but separate
results had to be
reported on type 2
diabetics in order to
be included in this
systematic review)

The intervention of all
studies included DSME.
The modes of DSME
delivery consisted of
individual or group
education, a combination of
individual and group
education, or remote
methods via online or
telephone.
Various providers delivered
DSME: healthcare
professionals including
physicians, diabetes
educators, registered
nurses, etc.

Baseline and Follow-up
(post-intervention)
hemoglobin A1cs were
measured as the primary
outcome.

Modes of DSME delivery:
Combination of education
demonstrated significant
improvement in hemoglobin A1c
levels.

Outcomes were analyzed
using Pearson’s chi-square.

Provider method: Approximately
70% of team interventions
demonstrated significant
improvement in hemoglobin A1c
levels compared to only 56% of
solo interventions. Analysis of
results using Pearson’s chi-square
did not determine significance
between team or solo methods.
Additionally, there was a mean
improvement in hemoglobin A1c
levels of -0.74 in both methods.

Strengths:
Researchers
identified and
addressed
heterogeneity;
Researchers
provided tables
making it easy to
follow and review
single studies.
Authors provided
analysis.
Appropriate
search strategy
presented.
Numerous RCTs
included in SR.
Limitations:

In this SR, provider type
was classified as either
solo or team.
Duration of DSME was
classified as either less
than or equal to 10 hours
or greater than 10 hours.

Those with a higher hemoglobin
A1c at baseline demonstrated
significant improvement in levels
following DSME interventions.
Those participating in DSME for
greater than 10 hours
demonstrated significantly greater
changes in 70% of interventions.

None
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120 RCTs were
included in this
review.

Garber, A. J.
(et al.)
2021
Good Quality
(B)

Purpose: To
provide guidance to
healthcare providers
on how to
comprehensively
manage patients
who have type 2
diabetes

Patient education on
lifestyle modifications,
packaged/processed food
nutrition labels, dietary
measures, weight control,
physical activity, smoking
cessation, blood glucose
monitoring.

Design:
Consensus/Position
Statement

Physical activity consisting
of greater than or equal to
150 minutes of moderateintensity activity each
week.

Population:
Individuals who have
type 2 diabetes

Khanh-Dao Le,
L.
2021
High Quality (A)

Purpose: To
determine the best
evidence “regarding
individual dietary
teaching compared
to group teaching for
HGa1c control in
newly diagnosed
adults with type 2
diabetes”
Design: Evidence
Summary

Hemoglobin A1c, blood
pressure, lipid levels, and
weight are routinely
measured in diabetes care.
Hemoglobin A1c is an
established biomarker for
glycemic control and is
measured every 3 months
until stable.

Diabetes self-management
education delivered in an
individualized format

Treatment plans should include
individualized hemoglobin A1c
target goal(s); A target
hemoglobin A1c goal of less than
or equal to 6.5% is ideal as long
as it can be achieved safely.

Strengths:
Provides
comprehensive
details of T2DM
algorithm,
includes key
stakeholders
Limitations:
Does not report
search strategy

Patients should be seen for
diabetes management every 3
months until their diseases is wellcontrolled.

Establishing goals centered
on weight loss/control,
physical activity, diet.
Pharmacotherapy and
continuous glucose
monitoring may be
necessary for certain
patients.
Diabetes self-management
education delivered in a
group-based format

The overall mean reduction in
hemoglobin A1c levels in all
participants combined was 0.74
(SD, 0.63).
Lifestyle modifications are
multifaceted (diet, weight control,
physical activity, blood glucose
monitoring, medication
compliance) and should be
ongoing.

The effect of diabetes selfmanagement education on
hemoglobin A1c levels was
measured.
Secondary outcomes were
also measures which
included psychosocial,
lifestyle, and clinical
improvements.
Attendance rates of a groupbased format was
measured.

One systematic review supports
group-based diabetes selfmanagement due to its costeffectiveness and report of
significantly reducing hemoglobin
A1c.
However, a qualitative study found
that attendance rates for groupbased education formats are low
and an RCT identified no
differences between peer-support,
group-based education and
individual sessions on hemoglobin
A1c.

Strengths: The
author included
qualitative
studies to
determine
participants’
viewpoints and
limitations.
Limitations:
Statistical data
was not
provided.
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Sample: Adults
newly diagnosed
with type 2 diabetes

One RCT demonstrated that an
individualized format involving
telephone interventions and
educational mailings focused on
small changes in diet and physical
activity significantly improved
hemoglobin a1c levels, DBP, and
weight in women.

1 systematic review
with meta-analysis
involving 21 RCTs, 3
single RCTs, 2
qualitative studies,
and 1 position
statement were
included in the
evidence summary
sample

Khan-Dao Le, L.
2021
High Quality (A)

Purpose: To
determine the best
evidence regarding
the effectiveness of
diabetes selfmanagement
education
Design: Evidence
Summary
Sample: Patients
who have diabetes
1 systematic review
and meta-analysis
involving 8 RCTs, 11
systematic reviews
involving 511 studies
(167+ RCTs), 1
single RCT, and 1
CPG were included

Interventions aimed at impacting
individual food consumption,
regardless of educational format,
is a critical component of TIIDM
education and diabetes selfmanagement.

Individual self-management
education
Diabetes self-management
education or instruction:
goal setting, medication
compliance, interpreting
blood sugar results
Exercise
Goal setting
Follow-up telephone calls
monitoring patient’s
progress toward meeting
goals that were set with the
clinician during an
individual visit
Diabetes self-management
tools listing goals and plan
to better help patients

Hemoglobin A1c
Quality of life,
Psychological/Psychosocial,
Clinical outcomes

Current evidence does not clearly
denote which format of dietary
teaching/self-management is best.
Clinical judgement should be
utilized by healthcare
professionals.
One systematic review reported
an absolute reduction in
hemoglobin A1c of 0.57.
Interventions aimed at improving
knowledge of diabetes, selfmanagement skills, and active
participation centered around goal
setting demonstrated a mean
reduction in hemoglobin A1c of
0.74.
All patient who have diabetes
should receive self-management
education centered on diet,
physical activity, medication
compliance, blood sugar
monitoring, and reducing risks
such as smoking cessation.

Strengths: The
author included
numerous high
quality pieces of
evidence in the
summary.
Statistical data
was provided for
readers.
Limitations:
None identified
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in the evidence
summary sample

Ombech, E.
2021
High Quality (A)

Purpose: To
determine the best
evidence “regarding
the effectiveness of
self-monitoring of
blood glucose
(SMBG)”

monitor progress and selfmanage diabetes
Active participation
Structured and/or
unstructured selfmonitoring of blood glucose

The effect of SMBG on
glycemic control/hemoglobin
A1c was measured.

Continuous glucose
monitoring

Self-monitoring of blood glucose,
regardless of the method utilized,
is beneficial in reducing
hemoglobin A1c and should be
considered an important strategy
in diabetes self-management.

Design: Evidence
Summary

Limitations:
Statistical data
was not
provided.

Sample: Patients
with type 2 diabetes
mellitus

Podder, V.
2021
High Quality (A)

2 systematic reviews
and meta-analysis
involving 29 RCTs, 3
systematic reviews
involving 53 RCTs,
and 2 single RCTs
were included in the
evidence summary
sample
Purpose: To
determine the best
evidence regarding
educational support
for self-managed
TIIDM in a
community setting.
Design: Evidence
Summary
Sample: Patients
who have diabetes
3 systematic reviews
and meta-analysis
involving 69 RCTs,

Strengths:
Evidence about
both methods of
monitoring blood
glucose were
evaluated by the
author.

Diabetes self-management
education: communication,
education, health data,
feedback

The effect of diabetes selfmanagement education on
Hemoglobin A1c was
measured.

Individual vs. group-based
educational format

In one systematic review,
weight, waist circumference,
lipid levels, fasting blood
glucose, and knowledge of
diabetes was measured.

Comparison group: usual
care consisting of minimal
diabetes education and/or
intervention

One systematic review reported
communication, education,
feedback, and health data as
essential elements to improving
hemoglobin A1c levels.
Engagement in diabetes selfmanagement
education/intervention compared
to minimal education/intervention
significantly improves hemoglobin
A1c levels both statistically and
clinically. A mean reduction in
hemoglobin of 0.74 was reported
for the diabetes self-management
group.

Strengths: The
author included
numerous high
quality pieces of
evidence in the
summary.
Statistical data
was provided for
readers.
Limitations:
None identified

65
and 4 systematic
reviews were
included in the
evidence summary
sample

Pogach, L.
(et al.)
2017
High Quality (A)

Purpose: To
provide guidance to
healthcare providers
on how to manage
type 2 diabetes
mellitus in the
primary care setting
Design: Clinical
practice guideline
Sample: Nonpregnant/Nursing
adults who have
type 2 diabetes
mellitus and are
eligible to receive
care at the VA/DOD
healthcare systems
– this includes
veterans, their
families, etc.

One systematic review reported a
greater reduction in hemoglobin
A1c levels at 6-, 12-, and 18months for those participating in a
group-based educational format.
There was no notable difference
in hemoglobin levels between the
group-based and individual DSME
format at 24-months. DSME
produced favorable outcomes for
weight, waist circumference, lipid
levels, fasting blood glucose, and
diabetes knowledge.

Shared-decision making
and patient-centered care
are vital components of
diabetes treatments.
Treatment plans should be
individualized and include
the patients’ needs and
goals, including lifestyle
changes (physical activity,
diet/nutrition, smoking
cessation, weight
loss/control) and a
hemoglobin A1c target
range.
Comprehensive diabetes
self-management
education (DSMS)
includes: diet, physical
activity, self-monitoring of
blood glucose, tools to
identify or integrate the
patients’ goals, etc.

Hemoglobin A1c level
serves as a glycemic control
indicator.
DSME has been
demonstrated to decrease
hemoglobin A1c levels and
BMI.
A lower-carb diet has been
demonstrated to improve
glycemic control
(hemoglobin A1c levels).

Diabetes self-management
education and interventions
produces favorable outcomes.
Resources for DSME in the
community setting should be
determined at the clinicians own
judgement.
A target hemoglobin A1c range for
uncomplicated diabetic patients is
6.0-7.0%
Although DSMS is a newer
concept, ongoing support such as
intermittent follow-up and the
evaluation of and re-establishment
of goals improved outcomes
The clinician and patient should
decide on a personalized
hemoglobin A1c target and
behavioral/lifestyle goals together.
Patients should be provided with
DSME and DSMS either
individually or in a group format to
help them understand and
successfully manage their
diagnosis and perform lifestyle
changes.

Strengths: All
around strong
CPG
Limitations:
None identified
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Riddle, M. C.
(et al.)
2019

Purpose: To
provide guidance to
clinicians on the
management of
diabetes

High Quality (A)
Design: Clinical
practice guideline
Population:
Individuals who are
diagnosed with
diabetes

Sherifali, D.
(et al.)
2016

Diabetes self-management
support (DSMS) includes
ongoing support to
evaluate progress on
personal goals, knowledge
of diagnosis, assessment
of DSM skills, and reeducation as needed.
Fundamental elements of
diabetes treatment involve
patient centered care
including diabetes selfmanagement education
and support (DSMES),
physical activity, dietary
counseling and smoking
cessation.

Design: Systematic
review with metaanalysis.
Sample: 724 Nonpregnant adults who
had type 2 diabetes

Coaching intervention
methods/sessions
included: telephone only, a

High Quality (A)

DSMES improves knowledge of
the diagnosis, self-care,
hemoglobin A2c levels, quality of
life, and weight.

BMI is routinely measured at
diabetes follow-up visits.

Hemoglobin levels should be
routinely measured every 3months until target goals have
been maintained. Point of care
testing is an appropriate and
timely measure for this.

Interventions should
include a low-carb diet, 30
minutes of aerobic activity
daily (broken up as
necessary to meet the
needs of the patient)
working up to 150 minutes
each week of moderateintensity physical activity.
Self-monitoring of blood
glucose may be utilized for
certain patients.
All RCTs included in this
study implemented a health
coach intervention. The
authors define health
coaching as “health-related
education, behavior
change and support by a
healthcare professional” (p.
85).

Purpose: To
determine the
effectiveness of
health coaching on
glycemic control.

Hemoglobin A1c is
measured as an indicator of
glycemic control over the
course of 3-months.

Strengths: All
around strong
CPG. Very
detailed.
Provides
references to
studies within
text. Includes key
stakeholders.
Limitations:
None identified.

Low-carb diets improve glycemic
control.
Resistance exercise has been
demonstrated to lower
hemoglobin A1c levels.
Weight management is in integral
part of diabetes care.

The primary outcome
measured was hemoglobin
A1c levels.
All RCTs reported
hemoglobin A1c changes.

Health coaching demonstrated the
following pooled effect: a reduced
hemoglobin A1c level of 0.32%
(95% CI, -0.50 to -0.15)
Short term health coaching (less
than 6 months) demonstrated a
significant decrease in
hemoglobin A1c levels (0.23%)
(95% CI, -0.37 to -0.09)

Strengths: The
researchers took
into account the
heterogeneity of
the studies.
Provided indepth information
of each study on
tables.
Limitations: None
identified.
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8 RCTs were
included in this
review.

combination of telephone
and face-to-face, or a
combination of telephone,
internet, and face-to face
Coaching interventions
consisted of goal
setting/achievement,
improving diabetes selfcare
management/knowledge,
individualized
recommendations, and/or
frequent follow-up.

Standiford, C. J.
(et al.)
2019
High Quality (A)

Purpose: To
provide guidance to
healthcare providers
on how to manage
type 2 diabetes
mellitus
Design: Clinical
practice guideline
Sample: Adults who
have type 2 diabetes
mellitus

The control groups
received the usual/formal
standard of care diabetes
education and support.
Critical elements of
treatment for type 2
diabetes includes selfmanagement education
and tools, lifestyle
interventions/changes, goal
setting, and blood glucose
control.
Diabetes self-management
topics include: daily selfcare, knowledge of and
progress towards
hemoglobin a1c
levels/goals, blood glucose
monitoring, medication
compliance, symptoms of
hyper- and hypoglycemia,
physical activity, meal
planning, weight loss, and
stress/coping
Goals should be centered
around the aforementioned
DSM topics

Hemoglobin A1c is
measured every 3-months if
one is on insulin or their
diabetes is not wellcontrolled.
Blood pressure, weight, and
BMI are assessed at each
diabetes visit.
A hemoglobin A1c greater
than 6.5% indicates
diabetes.

Individuals should regularly visit
their primary care provider every
3- or 6-months.
A target hemoglobin A1c for
patients with TIIDM is equal or
less than 7%.
Patients whose Hemoglobin A1c
level is not at or below target or
who have undergone changes to
either diabetic medications or
lifestyle should have their
hemoglobin measured every 3months.
Diet and physical activity should
be reviewed and reinforced at
every visit.
Meal Planning should include
portion control, healthy choices,
and/or monitoring carbohydrate
intake

Strengths:
Strong CPG,
easy to
understand and
follow, addresses
population of
interest very
clearly, includes
necessary
stakeholders
Limitations:
None identified.

68

Waring, A.
(et al.)
2021
Good Quality
(B)

Purpose: To
provide guidance to
healthcare providers
on how to
appropriately treat
type 2 diabetes
mellitus

Diabetes treatment include
lifestyle modifications such
as diet, physical activity,
weight management, foot
care, medication
compliance, and blood
glucose monitoring.

Design: Clinical
practice guideline

Establish risk-reduction
goals and a balance
between dietary intake and
physical activity

Population:
Individuals who have
type 2 diabetes

Perform or work up to 30
minutes or more of
moderate-intensity
exercise. Break-up physical
activity into increments as
needed.
Consume a low-carb,
Mediterranean diet (whole
grains, nuts, fruits, and
vegetables, legumes, fish,
etc.).

Hemoglobin A1c, blood
pressure, lipid levels, and
weight are routinely
measured in diabetes care.

Goals centered around diabetes
self-management should be set
with each patient.
Self-monitoring of blood glucose
proves beneficial when results are
used to make lifestyle changes or
adjustments.

A hemoglobin A1c greater
than 6.5% indicates
diabetes.

Hemoglobin A1c levels should be
evaluated every 3-months until the
target goal is achieved.

Strengths:
Includes key
stakeholders,
addresses
population of
interest, easy to
follow and
understand.
Limitations:
Does not provide
search strategy.
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APPENDIX D
Demographic Form and DSMQ
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APPENDIX E
Informed Consent
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APPENDIX F
SMART Goals Carbon Copy Worksheet

Note: This SMART Goals Worksheet was created by the project leader.
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APPENDIX G
Participant Handout Folder

Note: This is a “free, reproducible handout” from the American Diabetes Association and can be found at
https://professional.diabetes.org/pel/type-2-diabetes-english

76

Note: This is a “free, reproducible handout” from the American Diabetes Association and can be found at
https://professional.diabetes.org/pel/small-steps-health-english
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Note: This is a “free, reproducible handout” from the American Diabetes Association and can be found at
http://main.diabetes.org/dorg/PDFs/awareness-programs/hhm/what_can_i_eat-best_foods-American_Diabetes_Association.pdf
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Note: This is a “free, reproducible handout” from the American Diabetes Association and can be found at
https://professional.diabetes.org/pel/making-choices-using-food-labels-english-0
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Note: This is a “free, reproducible handout” from the American Diabetes Association and can be found at
https://professional.diabetes.org/pel/physical-activity-english
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Note: This is a “free, reproducible handout” from the American Diabetes Association and can be found at
https://professional.diabetes.org/pel/desk-exercises-english
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Note: This is a “free, reproducible handout” from the American Diabetes Association and can be
found at https://professional.diabetes.org/pel/factors-affecting-blood-sugar-english
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Note: This is a “free, reproducible handout” from the American Diabetes Association and can be found at
https://professional.diabetes.org/pel/checking-blood-glucose-english
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Note: This is a “free, reproducible handout” from the American Diabetes Association and can be found at
https://professional.diabetes.org/pel/low-blood-glucose-hypoglycemia-english
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Note: This is a “free, reproducible handout” from the American Diabetes Association and can be found at
https://professional.diabetes.org/pel/medications-treating-type-2-diabetes-english
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Note: This weekly food, exercise, blood glucose monitoring, and medication log was created by the project leader.
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Note: This diabetes self-management journal was created by the project leader. There are approximately 5 pages containing blank
lines in the journals provided in the participant handout folder.
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Note: These booklets were purchased by the project leader from the American Diabetes Association and were included in each
participant handout folder. These can be purchased from the American Diabetes Association at the following website:
https://shopdiabetes.org/collections/patient-education-handouts
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Note: This placemat was purchased by the project leader from the American Diabetes
Association and was included in each participant handout folder. This can be purchased from the
American Diabetes Association at the following website:
https://shopdiabetes.org/collections/patient-education-handouts
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APPENDIX H
2-Week Reminder Letter Template and SMART Goals Worksheet
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APPENDIX I
8-Week Reminder Letter Template and SMART Goals Worksheet
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APPENDIX J
4-Week Progress Telephone Call Template Guide
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APPENDIX K
12-Week Satisfaction Questionnaire and DSMQ
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APPENDIX L
DSMQ Permission for Use and Reprint
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APPENDIX M
PowerPoint for Stakeholders
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APPENDIX N
Valparaiso University’s IRB Exemption
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APPENDIX O
EBP Project Implementation Calendar
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APPENDIX P
Project Leader’s Ethics Training Certificate
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APPENDIX Q
Graphs of Demographic Data
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APPENDIX R
Graph of Improved Hemoglobin A1c Levels
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APPENDIX S
Mean Scores of DSMQ
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APPENDIX T
Pie Graphs of SMART Goals
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APPENDIX U
Mailed Appreciation Letter Sent with Final Questionnaire

